Tau protein isoforms, phosphorylation and role in neurodegenerative disorders

Brain Research Reviews

Volumn 33, Issue 1, 2000, Pages 95-130

  Buée, Luc ^a   Bussière, Thierry ^c   Buée Scherrer, Valérie ^b   Delacourte, André ^a   Hof, Patrick R ^c  

^a INSERM   (France)

^b UNIVERSITÉ D'ARTOIS   (France)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Isoforms aggregation; Isoforms phosphorylation; Neurodegenerative disorder; Tau protein

Indexed keywords

ISOPROTEIN; TAU PROTEIN; TUBULIN;

ALZHEIMER DISEASE; ARTICLE; CELL SHAPE; CHROMOSOME 17; DEGENERATIVE DISEASE; DOWN SYNDROME; FRONTOTEMPORAL DEMENTIA; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; MICROTUBULE ASSEMBLY; MYOTONIC DYSTROPHY; NERVE FIBER TRANSPORT; NIEMANN PICK DISEASE; NONHUMAN; PARKINSONISM; PATHOGENESIS; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

EID: 0033850407     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(00)00019-9     Document Type: Review

References (425)

1. Consensus report of the Working Group, Molecular and biochemical markers of Alzheimer's disease. the Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on aging working group, Neurobiol. Aging 19 (1998) 109-116, published erratum appears in Neurobiol. Aging 119 (1998) 1285.
2. E.J. Aamodt, R.C.J. Williams, Microtubule-associated proteins connect microtubules and neurofilaments in vitro, Biochemistry 23 (1984) 6023-6031.
3. M.L. Albert, R.G. Feldman, A.L. Willis, The subcortical dementia of progressive supranuclear palsy, J. Neurol. Neurosurg. Psychiatry 37 (1974) 121-130.
4. A. Andreadis, J.A. Broderick, K.S. Kosik, Relative exon affinities and suboptimal splice site signals lead to non-equivalence of two cassette exons, Nucleic Acids Res. 23 (1995) 3585-3593.
5. A. Andreadis, W.M. Brown, K.S. Kosik, Structure and novel exons of the human tau gene, Biochemistry 31 (1992) 10626-10633.
6. A. Andreadis, B.K. Wagner, J.A. Broderick, K.S. Kosik, A tau promoter region without neuronal specificity, J. Neurochem. 66 (1996) 2257-2263.
7. N. Andreasen, L. Minthon, A. Clarberg, P. Davidsson, J. Gottfries, E. Vanmechelen, H. Vanderstichele, B. Winblad, K. Blennow, Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample, Neurology 53 (1999) 1488-1494.
8. N. Andreasen, L. Minthon, E. Vanmechelen, H. Vanderstichele, P. Davidsson, B. Winblad, K. Blennow, Cerebrospinal fluid tau and beta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment, Neurosci. Lett. 273 (1999) 5-8.
9. N. Andreasen, E. Vanmechelen, A. Van de Voorde, P. Davidsson, C. Hesse, S. Tarvonen, I. Raiha, L. Sourander, B. Winblad, K. Blennow, Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow-up study, J. Neurol. Neurosurg. Psychiatry 64 (1998) 298-305.
10. D.M. Appelt, B.J. Balin, The association of tissue transglutaminase with human recombinant tau results in the formation of insoluble filamentous structures, Brain Res. 745 (1997) 21-31.
11. H. Arai, Y. Morikawa, M. Higuchi, T. Matsui, C.M. Clark, M. Miura, N. Machida, VM.Y. Lee, J.Q. Trojanowski, H. Sasaki, Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology, Biochem. Biophys. Res. Commun. 236 (1997) 262-264.
12. H. Arai, M. Terajima, M. Miura, S. Higuchi, T. Muramatsu, N. Machida, H. Seiki, S. Takase, C.M. Clark, V.M.Y. Lee, J.Q. Trojanowski, H. Sasaki, Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease, Ann. Neurol. 38 (1995) 649-652.
13. C.S. Arnold, G.V. Johnson, R.N. Cole, D.L.Y. Dong, M. Lee, G.W. Hart, The microtubule-associated protein tau is extensively modified with O-linked W-acetylglucosamine, J. Biol. Chem. 271 (1996) 28741-28744.
14. S.E. Arnold, B.T. Hyman, J. Flory, A.R. Damasio, G.W. Van Hoesen, The topographical and neuroanatomical distribution of neurofibril-lary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease, Cereb. Cortex 1 (1991) 103-116.
15. M. Arrasate, M. Perez, J.M. Valpuesta, J. Avila, Role of glycos-aminoglycans in determining the helicity of paired helical filaments, Am. J. Pathol. 151 (1997) 1115-1122.
16. I.A. Auer, M.L. Schmidt, V.M.Y. Lee, B. Curry, K. Suzuki, R.W. Shin, P.G. Pentchev, E.D. Carstea, J.Q. Trojanowski, Paired helical filament tau (PHF-tau) in Niemann-Pick type C disease is similar to PHF-tau in Alzheimer's disease, Acta Neuropathol. 90 (1995) 547551.
17. M. Baker, I. Litvan, H. Houlden, J. Adamson, D. Dickson, J. Perez-Tur, J. Hardy, T. Lynch, E. Bigio, M. Hutton, Association of an extended haplotype in the tau gene with progressive supranuclear palsy, Hum. Mol. Genet. 8 (1999) 711-715.
18. M.J. Ball, Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia. A quantitative study, Acta Neuropathol. 37 (1977) 111-118.
19. C. Bancher, H. Leitner, K. Jellinger, H. Eder, U. Setinek, P. Fischer, J. Wegiel, H.M. Wisniewski, On the relationship between measles virus and Alzheimer neurofibrillary tangles in subacute sclerosing panencephalitis, Neurobiol. Aging 17 (1996) 527-533.
20. J. Baudier, R.D. Cole, Phosphorylation of tau proteins to a state like that in Alzheimer's brain is catalyzed by a calcium/calmodulin-dependent kinase and modulated by phospholipids, J. Biol. Chem. 262 (1987) 17577-17583.
21. K. Baumann, E.M. Mandelkow, J. Biernat, H. Piwnica-Worms, E. Mandelkow, Abnormal Alzheimer-like phosphorylation of tau protein by cyclin-dependent kinases cdk2 and cdk5, FEBS Lett. 336 (1993) 417-424.
22. P. Bennett, V. Bonifati, U. Bonuccelli, C. Colosimo, M. De Mari, G. Fabbrini, R. Marconi, G. Meco, D.J. Nicholl, F. Stocchi, N. Vanacore, P. Vieregge, A.C. Williams, Direct genetic evidence for involvement of tau in progressive supranuclear palsy. European Study Group on Atypical Parkinsonism Consortium, Neurology 51 (1998) 982-985.
23. W.C. Benzing, E.J. Mufson, Apolipoprotein E immunoreactivity within neurofibrillary tangles: relationship to Tau and PHF in Alzheimer's disease, Exp. Neurol. 132 (1995) 162-171.
24. C. Bergeron, M.S. Pollanen, L. Weyer, A.E. Lang, Cortical degeneration in progressive supranuclear palsy. A comparison with cortical-basal ganglionic degeneration, J. Neuropathol. Exp. Neurol. 56 (1997) 726-734.
25. L.M. Bierer, P.R. Hof, D.P. Purohit, L. Carlin, J. Schmeidler, K.L. Davis, D.P. Perl, Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease, Arch. Neurol. 52 (1995) 81-88.
26. J. Biernat, N. Gustke, G. Drewes, E.M. Mandelkow, E. Mandelkow, Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding, Neuron 11 (1993) 153-163.
27. E.H. Bigio, D.F. Brown, C.L. White 3rd, Progressive supranuclear palsy with dementia: cortical pathology, J. Neuropathol. Exp. Neurol. 58 (1999) 359-364.
28. L.I. Binder, A. Frankfurter, L.I. Rebhun, The distribution of tau in the mammalian central nervous system, J. Cell Biol. 101 (1985) 1371-1378.
29. T.D. Bird, E.M. Wijsman, D. Nochlin, M. Leehey, S.M. Sumi, H. Payami, P. Poorkaj, E. Nemens, M. Rafkind, G.D. Schellenberg, Chromosome 17 and hereditary dementia: linkage studies in three non-Alzheimer families and kindreds with late-onset FAD, Neurology 48 (1997) 949-954.
30. K. Blennow, E. Vanmechelen, Combination of the different biological markers for increasing specificity of in vivo Alzheimer's testing, J. Neural. Transm. Suppl. 53 (1998) 223-235.
31. K. Blennow, A. Wallin, H. Agren, C. Spenger, J. Siegfried, E. Vanmechelen, Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?, Mol. Chem. Neuropathol. 26 (1995) 231-245.
32. K.J. Bohm, W. Vater, P. Steinmetzer, S.A. Kusnetsov, V.I. Rodionov, V.I. Gelfand, E. Unger, Effect of MAP1, MAP2, and tau proteins on structural parameters of tubulin assemblies, Acta Histochem. Suppl. 39 (1990) 357-364.
33. V. Bonifati, M. Joosse, D.J. Nicholl, N. Vanacore, P. Bennett, P. Xj.t:( Lit. I uiuin lVLii Rizzu, G. Fabbrini, R. Marconi, C. Colosimo, N. Locuratolo, F. Stocchi, U. Bonuccelli, M. De Mari, G. Wenning, P. Vieregge, B. Oostra, G. Meco, P. Heutink, The tau gene in progressive supranu-clear palsy: exclusion of mutations in coding exons and exon 10 splice sites, and identification of a new intronic variant of the disease-associated H1 haplotype in Italian cases, Neurosci. Lett. 274 (1999) 61-65.
34. C. Bouras, P.R. Hof, P. Giannakopoulos, J.P. Michel, J.H. Morrison, Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital, Cereb. Cortex 4 (1994) 138-150.
35. C. Bouras, P.R. Hof, J.H. Morrison, Neurofibrillary tangle densities in the hippocampal formation in a non-demented population define subgroups of patients with differential early pathologic changes, Neurosci. Lett. 153 (1993) 131-135.
36. E. Braak, H. Braak, Alzheimer's disease: transiently developing dendritic changes in pyramidal cells of sector CA1 of the Amnion's horn, Acta Neuropathol. 93 (1997) 323-325.
37. H. Braak, E. Braak, On areas of transition between entorhinal allocortex and temporal isocortex in the human brain. Normal morphology and lamina-specific pathology in Alzheimer's disease, Acta Neuropathol. 68 (1985) 325-332.
38. H. Braak, E. Braak, Demonstration of amyloid deposits and neuro-fibrillary changes in whole brain sections, Brain Pathol. 1 (1991) 213-216.
39. H. Braak, E. Braak, Neuropathological stageing of Alzheimer-related changes, Acta Neuropathol. 82 (1991) 239-259.
40. R.M. Brady, R.P. Zinkowski, L.I. Binder, Presence of tau in isolated nuclei from human brain, Neurobiol. Aging 16 (1995) 479-486.
41. G.T. Bramblett, M. Goedert, R. Jakes, S.E. Merrick, J.Q. Tro-janowski, VM.Y. Lee, Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding, Neuron 10 (1993) 1089-1099.
42. R. Brandt, G. Lee, The balance between tau protein's microtubule growth and nucleation activities: implications for the formation of axonal microtubules, J. Neurochem. 61 (1993) 997-1005.
43. R. Brandt, J. Leger, G. Lee, Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain, J. Cell Biol. 131 (1995) 1327-1340.
44. J.P. Brion, A.M. Couck, E. Passareiro, J. Flament-Durand, Neuro-fibrillary tangles of Alzheimer's disease: an immunohistochemical study, J. Submicrosc. Cytol. 17 (1985) 89-96.
45. J.P. Brion, D.P. Hanger, A.M. Couck, B.H. Anderton, A68 proteins in Alzheimer's disease are composed of several tau isoforms in a phosphorylated state which affects their electrophoretic mobilities, Biochem. J. 279 (1991) 831-836.
46. J.P. Brion, G. Tremp, J.N. Octave, Transgenic expression of the shortest human tau affects its compartmentalization and its phos-phorylation as in the pretangle stage of Alzheimer's disease, Am. J. Pathol. 154 (1999) 255-270.
47. S. Brion, J. Plas, A. Jeanneau, Pick's disease. Anatomo-clinical point of view, Rev. Neurol. 147 (1991) 693-704.
48. J. Brown, Pick's disease, Baillieres Clin. Neurol. 1 (1992) 535-557.
49. A. Brun, B. Englund, L. Gustafson, U. Passant, D.M.A. Mann, D. Neary, J.S. Snowden, Clinical and neuropathological criteria for frontotemporal dementia, J. Neurol. Neurosurg. Psychiatry 57 (1994) 416-418.
50. L. Buee, P.R. Hof, R.E. Rosenthal, A. Delacourte, G. Fiskum, Tau proteins phosphorylation and proteolysis in a canine model of cerebral ischemia/reperfusion, Soc. Neurosci. Abstr. 22 (1996) 1897.
51. L. Buee, A. Delacourte, Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease, Brain Pathol. 9 (1999) 681-693.
52. L. Buee, W. Ding, J.P. Anderson, S. Narindrasorasak, R. Kisilevsky, N.J. Boyle, N.K. Robakis, A. Delacourte, B. Greenberg, H.M. Fillit, Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide, Brain Res. 627 (1993) 199-204.
53. L. Bueee, W. Ding, A. Delacourte, H. Fillit, Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide, Brain Res. 601 (1993) 154-163.
54. L. Bueee, W. Ding, P. Hof, N. Boyle, J. Anderson, J. Morrison, N. Robakis, A. Delacourte, H. Fillit, Alzheimer's disease: Binding of vascular and neuroblastoma proteoglycans to amyloid b protein A4, in: M. Nicolini, P. Zatta, B. Corain (Eds.), Advances in the Biosciences, Vol. 87, Pergamon Press, Oxford, UK, 1993, pp. 217218.
55. L. Bueee, J. Perez-Tur, B. Leveugle, V. Bueee-Scherrer, E.J. Mufson, A.J. Loerzel, M.C. Chartier-Harlin, D.P. Perl, A. Delacourte, P.R. Hof, Apolipoprotein E in Guamanian amyotrophic lateral sclerosis / parkinsonism-dementia complex: genotype analysis and relationships to neuropathological changes, Acta Neuropathol. 91 (1996) 247-253.
56. V. Bueee-Scherrer, L. Bueee, P.R. Hof, B. Leveugle, C. Gilles, A.J. Loerzel, D.P. Perl, A. Delacourte, Neurofibrillary degeneration in amyotrophic lateral sclerosis /parkinsonism-dementia complex of Guam. Immunochemical characterization of tau proteins, Am. J. Pathol. 146 (1995) 924-932.
57. V. Bueee-Scherrer, L. Bueee, B. Leveugle, D.P. Perl, P. Vermersch, P.R. Hof, A. Delacourte, Pathological tau proteins in postencephalitic parkinsonism: comparison with Alzheimer's disease and other neurodegenerative disorders, Ann. Neurol. 42 (1997) 356-359.
58. V. Bueee-Scherrer, O. Condamines, C. Mourton-Gilles, R. Jakes, M. Goedert, B. Pau, A. Delacourte, AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease, Mol. Brain Res. 39 (1996) 79-88.
59. V. Bueee-Scherrer, P.R. Hof, L. Bueee, B. Leveugle, P. Vermersch, D.P. Perl, C.W. Olanow, A. Delacourte, Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease, Acta Neuropathol. 91 (1996) 351-359.
60. O. Bugiani, J.R. Murrell, G. Giaccone, M. Hasegawa, G. Ghigo, M. Tabaton, M. Morbin, A. Primavera, F. Carella, C. Solaro, M. Grisoli, M. Savoiardo, M.G. Spillantini, F. Tagliavini, M. Goedert, B. Ghetti, Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau, J. Neuropathol. Exp. Neurol. 58 (1999) 667-677.
61. T. Bussiere, P.R. Hof, C. Mailliot, C.D. Brown, M.L. Caillet-Boudin, D.P. Perl, L. Bueee, A. Delacourte, Phosphorylated serine422 on tau proteins is a pathological epitope found in several diseases with neurofibrillary degeneration, Acta Neuropathol. 97 (1999) 221230.
62. K.A. Butner, M.W. Kirschner, Tau protein binds to microtubules through a flexible array of distributed weak sites, J. Cell Biol. 115 (1991) 717-730.
63. J. Buxton, P. Shelbourne, J. Davies, C. Jones, T. Van Tongeren, C. Aslanidis, P. de Jong, G. Jansen, M. Anvret, B. Riley, R. Williamson, K. Johnson, Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy, Nature 355 (1992) 547548.
64. M.L. Caillet-Boudin, A. Delacourte, Induction of a specific tau Alzheimer epitope in SY-5Y neuroblastoma cells, NeuroReport 8 (1996) 307-310.
65. V. Cambiazo, M. Gonzalez, R.B. Maccioni, DMAP-85: a tau-like protein from Drosophila melanogaster larvae, J. Neurochem. 64 (1995) 1288-1297.
66. M.F. Carlier, C. Simon, R. Cassoly, L.A. Pradel, Interaction between microtubule-associated protein tau and spectrin, Biochimie 66 (1984) 305-311.
67. E.D. Carstea, J.A. Morris, K.G. Coleman, S.K. Loftus, D. Zhang, C. Cummings, J. Gu, M.A. Rosenfeld, W.J. Pavan, D.B. Krizman, J. Nagle, M.H. Polymeropoulos, S.L. Sturley, Y.A. Ioannou, M.E. Higgins, M. Comly, A. Cooney, A. Brown, C.R. Kaneski, E.J. Blanchette-Mackie, N.K. Dwyer, E.B. Neufeld, T.Y. Chang, L. Liscum, J.F.I. Strauss, O. Kousaku, M. Zeigler, R. Carmi, J. Sokol, D. Markie, R.R. O'Neill, O.P. van Diggelen, M. Elleder, M.C. Patterson, R. O'Brady, M.T. Vanier, P.G. Pentchev, D.A. Tagle, Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis, Science 277 (1997) 228-231.
68. J. Chen, Y. Kanai, N.J. Cowan, N. Hirokawa, Projection domains of MAP2 and tau determine spacings between microtubules in dendrites and axons, Nature 360 (1992) 674-677.
69. J.S. Chen, K. Mehta, Tissue transglutaminase: an enzyme with a split personality, Int. J. Biochem. Cell. Biol. 31 (1999) 817-836.
70. K.M. Chen, T.N. Chase, Parkinsonism-dementia: extrapyramidal disorders, in: P.J. Vinken, G.W. Bruyn, H.L. Klawans (Eds.), Handbook of Clinical Neurology, Vol. 49, Elsevier, Amsterdam, 1986, pp. 167-183.
71. S.S. Chin, J.E. Goldman, Glial inclusions in CNS degenerative diseases, J. Neuropathol. Exp. Neurol. 55 (1996) 499-508.
72. T.Y. Chou, G.W. Hart, C.V. Dang, c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas, J. Biol. Chem. 270 (1995) 18961-18965.
73. L.N. Clark, P. Poorkaj, Z. Wszolek, D.H. Geschwind, Z.S. Nasreddine, B. Miller, D. Li, H. Payami, F. Awert, K. Markopoulou, A. Andreadis, I. D'Souza, V.M.Y. Lee, L. Reed, J.Q. Trojanowski, V. Zhukareva, T. Bird, G. Schellenberg, K.C. Wilhelmsen, Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17, Proc. Natl. Acad. Sci. USA 95 (1998) 13103-13107.
74. D.W. Cleveland, S.Y. Hwo, M.W. Kirschner, Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly, J. Mol. Biol. 116 (1977) 227-247.
75. D.W. Cleveland, S.Y. Hwo, M.W. Kirschner, Purification of tau, a microtubule-associated protein that induces assembly of micro-tubules from purified tubulin, J. Mol. Biol. 116 (1977) 207-225.
76. P. Cohen, P.T. Cohen, Protein phosphatases come of age, J. Biol. Chem. 264 (1989) 21435-21438.
77. C. Conrad, A. Andreadis, J.Q. Trojanowski, D.W. Dickson, D. Kang, X. Chen, W. Wiederholt, L. Hansen, E. Masliah, L.J. Thal, R. Katzman, Y. Xia, T. Saitoh, Genetic evidence for the involvement of tau in progressive supranuclear palsy, Ann. Neurol. 41 (1997) 277-281.
78. J. Constantinidis, J. Richard, R. Tissot, Pick's disease. Histological and clinical correlations, Eur. Neurol. 11 (1974) 208-217.
79. I. Correas, R. Padilla, J. Avila, The tubulin-binding sequence of brain microtubule-associated proteins, tau and MAP-2, is also involved in actin binding, Biochem. J. 269 (1990) 61-64.
80. J.A. Corsellis, C.J. Bruton, D. Freeman-Browne, The aftermath of boxing, Psychol. Med. 3 (1973) 270-303.
81. J.L. Cummings, D.F. Benson, Subcortical dementia. Review of an emerging concept, Arch. Neurol. 41 (1984) 874-879.
82. I. D'Souza, P. Poorkaj, M. Hong, D. Nochlin, VM.Y. Lee, T.D. Bird, G.D. Schellenberg, Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements, Proc. Natl. Acad. Sci. USA 96 (1999) 5598-5603.
83. B.M. Davis, M.E. McCurrach, K.L. Taneja, R.H. Singer, D.E. Housman, Expansion of a CUG trinucleotide repeat in the 3' untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts, Proc. Natl. Acad. Sci. USA 94 (1997) 7388-7393.
84. J.G. de Yebenes, J.L. Sarasa, S.E. Daniel, A.J. Lees, Familial progressive supranuclear palsy. Description of a pedigree and review of the literature, Brain 118 (1995) 1095-1103.
85. A. Delacourte, L. Buee, Normal and pathological Tau proteins as factors for microtubule assembly, Int. Rev. Cytol. 171 (1997) 167-224.
86. A. Delacourte, J.P. David, N. Sergeant, L. Buee, A. Wattez, P. Vermersch, F. Ghozali, C. Fallet-Bianco, F. Pasquier, F. Lebert, H. Petit, C. Di Menza, The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease, Neurology 52 (1999) 1158-1165.
87. A. Delacourte, A. Defossez, Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments, J. Neurol. Sci. 76 (1986) 173-186.
88. A. Delacourte, S. Flament, E.M. Dibe, P. Hublau, B. Sablonniere, B. Hemon, V Scherrer, A. Defossez, Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease. Demonstration with a panel of antibodies against Tau proteins, Acta Neuropathol. 80 (1990) 111-117.
89. A. Delacourte, Y. Robitaille, N. Sergeant, L. Buee, P.R. Hof, A. Wattez, A. Laroche-Cholette, J. Mathieu, P. Chagnon, D. Gauvreau, Specific pathological Tau protein variants characterize Pick's disease, J. Neuropathol. Exp. Neurol. 55 (1996) 159-168.
90. A. Delacourte, N. Sergeant, A. Wattez, D. Gauvreau, Y. Robitaille, Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their tau isoform distribution and phosphorylation, Ann. Neurol. 43 (1998) 193-204.
91. P. Delaere, C. Duyckaerts, Y. He, F. Piette, J.J. Hauw, Subtypes and differential laminar distributions of beta A4 deposits in Alzheimer's disease: relationship with the intellectual status of 26 cases, Acta Neuropathol. 81 (1991) 328-335.
92. M.B. Delisle, J.R. Murrell, R. Richardson, J.A. Trofatter, O. Rascol, X. Soulages, M. Mohr, P. Calvas, B. Ghetti, A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy, Acta Neuropathol. 98 (1999) 62-77.
93. D. Dewar, D. Dawson, Tau protein is altered by focal cerebral ischaemia in the rat: an immunohistochemical and immunoblotting study, Brain Res. 684 (1995) 70-78.
94. D. Dewar, D.I. Graham, G.M. Teasdale, J. McCulloch, Cerebral ischemia induces alterations in tau and ubiquitin proteins, Dementia 5 (1994) 168-173.
95. E. Di Maria, M. Tabaton, T. Vigo, G. Abbruzzese, E. Bellone, C. Donati, E. Frasson, R. Marchese, P. Montagna, D. Munoz, P. Pramstaller, G. Zanusso, F. Ajmar, P. Mandich, Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy, Ann. Neurol. 47 (2000), in press.
96. M. Ding, D.D. Vandre, High molecular weight microtubule-associ-ated proteins contain O-linked-W-acetylglucosamine, J. Biol. Chem. 271 (1996) 12555-12561.
97. D.L. Dong, Z.S. Xu, M.R. Chevrier, R.J. Cotter, D.W. Cleveland, G.W. Hart, Glycosylation of mammalian neurofilaments. Localization of multiple O-linked W-acetylglucosamine moieties on neurofilament polypeptides L and M, J. Biol. Chem. 268 (1993) 1667916687.
98. C.G. Dotti, G.A. Banker, L.I. Binder, The expression and distribution of the microtubule-associated proteins tau and microtubule-associated protein 2 in hippocampal neurons in the rat in situ and in cell culture, Neuroscience 23 (1987) 121-130.
99. D.N. Drechsel, A.A. Hyman, M.H. Cobb, M.W. Kirschner, Modulation of the dynamic instability of tubulin assembly by the micro-tubule-associated protein tau, Mol. Biol. Cell 3 (1992) 1141-1154.
100. G. Drewes, A. Ebneth, U. Preuss, E.M. Mandelkow, E. Mandelkow, MARK, a novel family of protein kinases that phosphor-ylate microtubule-associated proteins and trigger microtubule disruption, Cell 89 (1997) 297-308.
101. G. Drewes, B. Lichtenberg-Kraag, F. Doring, E.M. Mandelkow, J. Biernat, J. Goris, M. Doree, E. Mandelkow, Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimerlike state, EMBO J. 11 (1992) 2131-2138.
102. D.G. Drubin, M.W. Kirschner, Tau protein function in living cells, J. Cell Biol. 103 (1986) 2739-2746.
103. S.M. Dudek, G.V. Johnson, Transglutaminase catalyzes the formation of sodium dodecyl sulfate-insoluble, Alz-50-reactive polymers of tau, J. Neurochem. 61 (1993) 1159-1162.
104. S.M. Dudek, G.V. Johnson, Postnatal changes in serine/threonine protein phosphatases and their association with the microtubules, Dev. Brain Res. 90 (1995) 54-61.
105. C. Dumanchin, A. Camuzat, D. Campion, P. Verpillat, D. Hannequin, B. Dubois, P. Saugier-Veber, C. Martin, C. Penet, F. Charbonnier, Y. Agid, T. Frebourg, A. Brice, Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism, Hum. Mol. Genet. 7 (1998) 1825-1829.
106. C. Duyckaerts, M. Bennecib, Y. Grignon, T. Uchihara, Y. He, F. Piette, J.J. Hauw, Modeling the relation between neurofibrillary tangles and intellectual status, Neurobiol. Aging 18 (1997) 267-273.
107. C. Duyckaerts, J.J. Hauw, F. Bastenaire, F. Piette, C. Poulain, V. Rainsard, F. Javoy-Agid, P. Berthaux, Laminar distribution of neocortical senile plaques in senile dementia of the Alzheimer type, Acta Neuropathol. 70 (1986) 249-256.
108. A. Ebneth, R. Godemann, K. Stamer, S. Illenberger, B. Trinczek, E. Mandelkow, Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease, J. Cell. Biol. (1998) 777-794.
109. M. Ezquerra, P. Pastor, F. Valldeoriola, J.L. Molinuevo, R. Blesa, E. Tolosa, R. Oliva, Identification of a novel polymorphism in the promoter region of the tau gene highly associated to progressive supranuclear palsy in humans, Neurosci. Lett. 275 (1999) 183-186.
110. L. Fasulo, M. Visintin, M. Novak, A. Cattaneo, Tau truncation in Alzheimer's disease: expression of a fragment encompassing PHF core tau induces apoptosis in COS cells, Alzheimer's Rep. 1 (1998) 25-31.
111. M.B. Feany, D.W. Dickson, Widespread cytoskeletal pathology characterizes corticobasal degeneration, Am. J. Pathol. 146 (1995) 1388-1396.
112. M.B. Feany, H. Ksiezak-Reding, W.K. Liu, I. Vincent, S.H. Yen, D.W. Dickson, Epitope expression and hyperphosphorylation of tau protein in corticobasal degeneration: differentiation from progressive supranuclear palsy, Acta Neuropathol. 90 (1995) 37-43.
113. M.B. Feany, L.A. Mattiace, D.W. Dickson, Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and cor-ticobasal degeneration, J. Neuropathol. Exp. Neurol. 55 (1996) 53-67.
114. A. Ferreira, J. Busciglio, A. Caceres, Microtubule formation and neurite growth in cerebellar macroneurons which develop in vitro: evidence for the involvement of the microtubule-associated proteins, MAP1a, HMW-MAP2 and Tau, Dev. Brain Res. 49 (1989) 215-228.
115. S. Flament, A. Delacourte, P. Delaere, C. Duyckaerts, J.J. Hauw, Correlation between microscopical changes and Tau 64 and 69 biochemical detection in senile dementia of the Alzheimer type. Tau 64 and 69 are reliable markers of the neurofibrillary degeneration, Acta Neuropathol. 80 (1990) 212-215.
116. S. Flament, A. Delacourte, B. Hemon, A. Deefossez, Direct demonstration of abnormal phosphorylation of Tau microtubular proteins in Alzheimer's disease, C.R. Acad. Sci. III 308 (1989) 77-82.
117. S. Flament, A. Delacourte, D.M.A. Mann, Phosphorylation of Tau proteins: a major event during the process of neurofibrillary degeneration. A comparative study between Alzheimer's disease and Down's syndrome, Brain Res. 516 (1990) 15-19.
118. S. Flament, A. Delacourte, M. Verny, J.J. Hauw, F. Javoy-Agid, Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type, Acta Neuropathol. 81 (1991) 591-596.
119. L.M. Fleming, G.V. Johnson, Modulation of the phosphorylation state of tau in situ: the roles of calcium and cyclic AMP, Biochem. J. 309 (1995) 41-47.
120. L.S. Forno, Neuropathology ofParkinson's disease, J. Neuropathol. Exp. Neurol. 55 (1996) 259-272.
121. N.L. Foster, K. Wilhelmsen, A.A. Sima, M.Z. Jones, C.J. D'Amato, S. Gilman, Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference, Ann. Neurol. 41 (1997) 706-715.
122. D. Galasko, C. Clark, L. Chang, B. Miller, R.C. Green, R. Motter, P. Seubert, Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease, Neurology 48 (1997) 632-635.
123. Q.S. Gao, J. Memmott, R. Lafyatis, S. Stamm, G. Screaton, A. Andreadis, Complex regulation of tau exon 10, whose missplicing causes frontotemporal dementia, J. Neurochem. 74 (2000) 490500.
124. R.M. Garruto, Pacific paradigms of environmentally-induced neurological disorders: clinical, epidemiological and molecular perspectives, Neurotoxicology 12 (1991) 347-377.
125. T.D. Garver, K.A. Harris, R.A. Lehman, V.M.Y. Lee, J.Q. Trojanowski, M.L. Billingsley, Tau phosphorylation in human, primate, and rat brain: evidence that a pool of tau is highly phosphorylated in vivo and is rapidly dephosphorylated in vitro, J. Neurochem. 63 (1994) 2279-2287.
126. J.F. Geddes, A.J. Hughes, A.J. Lees, S.E. Daniel, Pathological overlap in cases of parkinsonism associated with neurofibrillary tangles. A study of recent cases of postencephalitic parkinsonism and comparison with progressive supranuclear palsy and Guama-nian parkinsonism-dementia complex, Brain 116 (1993) 281-302.
127. I.S. Georgieff, R.K. Liem, D. Couchie, C. Mavilia, J. Nunez, M.L. Shelanski, Expression of high molecular weight tau in the central and peripheral nervous systems, J. Cell Sci. 105 (1993) 729-737.
128. J. Gerstmann, E. Straussler, I. Scheinker, Uber eine eigernartige hereditar-familiare Erkrankung des Zentralnervensystems, Z. Neurol. 154 (1936) 736-762.
129. B. Ghetti, S.R. Dlouhy, G. Giaccone, O. Bugiani, B. Frangione, M.R. Farlow, F. Tagliavini, Gerstmann-Straussler-Scheinker disease and the Indiana kindred, Brain Pathol. 5 (1995) 61-75.
130. B. Ghetti, P. Piccardo, B. Frangione, O. Bugiani, G. Giaccone, K. Young, F. Prelli, M.R. Farlow, S.R. Dlouhy, F. Tagliavini, Prion protein amyloidosis, Brain Pathol. 6 (1996) 127-145.
131. P. Giannakopoulos, P.R. Hof, C. Bouras, Dementia lacking distinctive histopathology: Clinicopathological evaluation of 32 cases, Acta Neuropathol. 89 (1995) 346-355.
132. P. Giannakopoulos, P.R. Hof, J.P. Michel, J. Guimon, C. Bouras, Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts, Brain Res. Rev. 25 (1997) 217-245.
133. S.D. Ginsberg, P.B. Crino, V.M.Y. Lee, J.H. Eberwine, J.Q. Trojanowski, Sequestration of RNA in Alzheimer's disease neuro-fibrillary tangles and senile plaques, Ann. Neurol. 41 (1997) 200-209.
134. M. Goedert, C.P. Baur, J. Ahringer, R. Jakes, M. Hasegawa, M.G. Spillantini, M.J. Smith, F. Hill, PTL-1, a microtubule-associated protein with tau-like repeats from the nematode Caenorhabditis elegans, J. Cell Sci. 109 (1996) 2661-2672.
135. M. Goedert, M. Hasegawa, R. Jakes, S. Lawler, A. Cuenda, P. Cohen, Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases, FEBS Lett. 409 (1997) 57-62.
136. M. Goedert, R. Jakes, Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization, EMBO J. 9 (1990) 4225-4230.
137. M. Goedert, R. Jakes, R.A. Crowther, Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments, FEBS Lett. 450 (1999) 306-311.
138. M. Goedert, R. Jakes, R.A. Crowther, P. Cohen, E. Vanmechelen, M. Vandermeeren, P. Cras, Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein, Biochem. J. 301 (1994) 871-877.
139. M. Goedert, R. Jakes, Z. Qi, J.H. Wang, P. Cohen, Protein phosphatase 2A is the major enzyme in brain that dephosphorylates tau protein phosphorylated by proline-directed protein kinases or cyclic AMP-dependent protein kinase, J. Neurochem. 65 (1995) 2804-2807.
140. M. Goedert, R. Jakes, M.G. Spillantini, M. Hasegawa, M.J. Smith, R.A. Crowther, Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosamino-glycans, Nature 383 (1996) 550-553.
141. M. Goedert, R. Jakes, E. Vanmechelen, Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205, Neurosci. Lett. 189 (1995) 167-169.
142. M. Goedert, M.G. Spillantini, N.J. Cairns, R.A. Crowther, Tau proteins of Alzheimer paired helical filaments: abnormal phos-phorylation of all six brain isoforms, Neuron 8 (1992) 159-168.
143. M. Goedert, M.G. Spillantini, R.A. Crowther, S.G. Chen, P. Parchi, M. Tabaton, D.J. Lanska,W.R. Markesbery, K.C. Wilhelmsen, D.W. Dickson, R.B. Petersen, P. Gambetti, Tau gene mutation in familial progressive subcortical gliosis, Nature Med. 5 (1999) 454-457.
144. M. Goedert, M.G. Spillantini, R. Jakes, D. Rutherford, R.A. Crowther, Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease, Neuron 3 (1989) 519-526.
145. M. Goedert, M.G. Spillantini, M.C. Potier, J. Ulrich, R.A. Crowther, Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain, EMBO J. 8 (1989) 393-399.
146. C.X. Gong, S. Shaikh, J.Z. Wang, T. Zaidi, I. Grundke-Iqbal, K. Iqbal, Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain, J. Neurochem. 65 (1995) 732-738.
147. B.L. Goode, P.E. Denis, D. Panda, M.J. Radeke, H.P. Miller, L. Wilson, S.C. Feinstein, Functional interactions between the pro-line-rich and repeat regions of tau enhance microtubule binding and assembly, Mol. Biol. Cell 8 (1997) 353-365.
148. B.L. Goode, S.C. Feinstein, Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau, J. Cell Biol. 124 (1994) 769-782.
149. S. Goto, H. Yamamoto, K. Fukunaga, T. Iwasa, Y. Matsukado, E. Miyamoto, Dephosphorylation of microtubule-associated protein 2, tau factor, and tubulin by calcineurin, J. Neurochem. 45 (1985) 276-283.
150. J. Gotz, A. Probst, M.G. Spillantini, T. Schafer, R. Jakes, K. Burki, M. Goedert, Somatodendritic localization and hyperphosphoryla-tion of tau protein in transgenic mice expressing the longest human brain tau isoform, EMBO J. 14 (1995) 1304-1313.
151. W.J. Goux, S. Rodriguez, D.R. Sparkman, Analysis of the core components of Alzheimer paired helical filaments. A gas chroma-tography /mass spectrometry characterization of fatty acids, carbohydrates and long-chain bases, FEBS Lett. 366 (1995) 81-85, Published erratum appears in FEBS Lett. 375 (1995) 1168.
152. W.J. Goux, S. Rodriguez, D.R. Sparkman, Characterization of the glycolipid associated with Alzheimer paired helical filaments, J. Neurochem. 67 (1996) 723-733.
153. A.J. Green, R.J. Harvey, E.J. Thompson, M.N. Rossor, Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's
154. S.G. Greenberg, P. Davies, J.D. Schein, L.I. Binder, Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau, J. Biol. Chem. 267 (1992) 564-569.
155. J.A. Greenwood, G.V. Johnson, Localization and in situ phosphorylation state of nuclear tau, Exp. Cell Res. 220 (1995) 332337.
156. J.A. Greenwood, C.W. Scott, R.C. Spreen, C.B. Caputo, G.V. Johnson, Casein kinase II preferentially phosphorylates human tau isoforms containing an amino-terminal insert. Identification of threonine 39 as the primary phosphate acceptor, J. Biol. Chem. 269 (1994) 4373-4380.
157. L.M. Griffith, T.D. Pollard, The interaction of actin filaments with microtubules and microtubule-associated proteins, J. Biol. Chem. 257 (1982) 9143-9151.
158. L.S. Griffith, B. Schmitz, O-linked W-acetylglucosamine is upregu-lated in Alzheimer brains, Biochem. Biophys. Res. Commun. 213 (1995) 424-431.
159. A. Grover, H. Houlden, M. Baker, J. Adamson, J. Lewis, G. Prihar, S. Pickering-Brown, K. Duff, M. Hutton, 5' splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10, J. Biol. Chem. 274 (1999) 15134-15143.
160. I. Grundke-Iqbal, K. Iqbal, M. Quinlan, Y.C. Tung, M.S. Zaidi, H.M. Wisniewski, Microtubule-associated protein tau. A component of Alzheimer paired helical filaments, J. Biol. Chem. 261 (1986) 6084-6089.
161. I. Grundke-Iqbal, K. Iqbal, Y.C. Tung, M. Quinlan, H.M. Wisniew-ski, L.I. Binder, Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology, Proc. Natl. Acad. Sci. USA 83 (1986) 4913-4917.
162. Y. Gu, F. Oyama, Y. Ihara, Tau is widely expressed in rat tissues, J. Neurochem. 67 (1996) 1235-1244.
163. L. Gustafson, Clinical picture of frontal lobe degeneration of non-Alzheimer type, Dementia 4 (1993) 143-148.
164. N. Gustke, B. Trinczek, J. Biernat, E.M. Mandelkow, E. Mandelkow, Domains of tau protein and interactions with microtubules, Biochemistry 33 (1994) 9511-9522.
165. R.S. Haltiwanger, S. Busby, K. Grove, S. Li, D. Mason, L. Medina, D. Moloney, G. Philipsberg, R. Scartozzi, O-glycosylation of nuclear and cytoplasmic proteins: regulation analogous to phos-phorylation?, Biochem. Biophys. Res. Commun. 231 (1997) 237242.
166. R.S. Haltiwanger, W.G. Kelly, E.P. Roquemore, M.A. Blomberg, L.Y. Dong, L. Kreppel, T.Y. Chou, G.W. Hart, Glycosylation of nuclear and cytoplasmic proteins is ubiquitous and dynamic, Biochem. Soc. Trans. 20 (1992) 264-269.
167. K.M. Hamre, B.T. Hyman, C.R. Goodlett, J.R. West, G.W. Van Hoesen, Alz-50 immunoreactivity in the neonatal rat: changes in development and co-distribution with MAP-2 immunoreactivity, Neurosci. Lett. 98 (1989) 264-271.
168. M.G. Hamshere, E.E. Newman, M. Alwazzan, B.S. Athwal, J.D. Brook, Transcriptional abnormality in myotonic dystrophy affects DMPK but not neighboring genes, Proc. Natl. Acad. Sci. USA 94 (1997) 7394-7399.
169. D.P. Hanger, J.P. Brion, J.M. Gallo, N.J. Cairns, P.J. Luthert, B.H. Anderton, Tau in Alzheimer's disease and Down's syndrome is insoluble and abnormally phosphorylated, Biochem. J. 275 (1991) 99-104.
170. D.P. Hanger, K. Hughes, J.R. Woodgett, J.P. Brion, B.H. Anderton, Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase, Neurosci. Lett. 147 (1992) 58-62.
171. A. Harada, K. Oguchi, S. Okabe, J. Kuno, S. Terada, T. Ohshima, R. Sato-Yoshitake, Y. Takei, T. Noda, N. Hirokawa, Altered microtubule organization in small-calibre axons of mice lacking tau protein, Nature 369 (1994) 488-491.
172. J.A. Hardy, G.A. Higgins, Alzheimer's disease: the amyloid cascade hypothesis, Science 256 (1992) 184-185.
173. P.S. Harper, Myotonic Dystrophy, 2nd Edition, Saunders, London, 1989.
174. G.W. Hart, L.K. Kreppel, F.I. Comer, C.S. Arnold, D.M. Snow, Z. Ye, X. Cheng, D. DellaManna, D.S. Caine, B.J. Earles, Y. Akimoto, R.N. Cole, B.K. Hayes, O-GlcNAcylation of key nuclear and cytoskeletal proteins: reciprocity with O-phosphorylation and putative roles in protein multimerization, Glycobiology 6 (1996) 711-716.
175. M. Hasegawa, R. Jakes, R.A. Crowther, V.M.Y. Lee, Y. Ihara, M. Goedert, Characterization of mAb AP422, a novel phosphoryla-tion-dependent monoclonal antibody against tau protein, FEBS Lett. 384 (1996) 25-30.
176. M. Hasegawa, M. Morishima-Kawashima, K. Takio, M. Suzuki, K. Titani, Y. Ihara, Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain, J. Biol. Chem. 267 (1992) 17047-17054.
177. M. Hasegawa, M.J. Smith, M. Goedert, Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly, FEBS Lett. 437 (1998) 207-210.
178. M. Hasegawa, M.J. Smith, M. Iijima, T. Tabira, M. Goedert, FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10, FEBS Lett. 443 (1999) 93-96.
179. J.J. Hauw, M. Verny, P. Delaere, P. Cervera, Y. He, C. Duyckaerts, Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer's disease and aging, Neurosci. Lett. 119 (1990) 182-186.
180. J.P. Henriquez, D. Cross, C. Vial, R.B. Maccioni, Subpopulations of tau interact with microtubules and actin filaments in various cell types, Cell Biochem. Funct. 13 (1995) 239-250.
181. A. Hershko, A. Ciechanover, The ubiquitin system, Annu. Rev. Biochem. 67 (1998) 425-479.
182. P. Heutink, M. Stevens, P. Rizzu, E. Bakker, J.M. Kros, A. Tibben, M.F. Niermeijer, C.M. van Duijn, B.A. Oostra, J.C. van Swieten, Hereditary frontotemporal dementia is linked to chromosome 17q21-q22: a genetic and clinicopathological study of three Dutch families, Ann. Neurol. 41 (1997) 150-159.
183. J.J. Higgins, I. Litvan, L.E. Nee, J.M. Loveless, A lack of the R406W tau mutation in progressive supranuclear palsy and cor-ticobasal degeneration, Neurology 52 (1999) 404-406.
184. J.J. Higgins, I. Litvan, L.T. Pho, W. Li, L.E. Nee, Progressive supranuclear gaze palsy is in linkage disequilibrium with the tau and not the alpha-synuclein gene, Neurology 50 (1998) 270-273.
185. A. Himmler, Structure ofthe bovine tau gene: alternatively spliced transcripts generate a protein family, Mol. Cell. Biol. 9 (1989) 1389-1396.
186. A. Himmler, D. Drechsel, M.W. Kirschner, D.W. Martin Jr., Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains, Mol. Cell. Biol. 9 (1989) 1381-1388.
187. A. Hirano, H.M. Dembitzer, L.T. Kurland, H.M. Zimmerman, The fine structure of some intraganglionic alterations. Neurofibrillary tangles, granulovacuolar bodies and 'rod-like' structures as seen in Guam amyotrophic lateral sclerosis and parkinsonism-dementia complex, J. Neuropathol. Exp. Neurol. 27 (1968) 167-182.
188. A. Hirano, L.T. Kurland, R.S. Krooth, S. Lessell, Parkinsonism-dementia complex, an endemic disease on the island of Guam I. Clinical features, Brain 84 (1961) 642-661.
189. A. Hirano, N. Malamud, T.S. Elizan, L.T. Kurland, Amyotrophic lateral sclerosis and Parkinsonism-dementia complex on Guam. Further pathologic studies, Arch. Neurol. 15 (1966) 35-51.
190. N. Hirokawa, T. Funakoshi, R. Sato-Harada, Y. Kanai, Selective stabilization of tau in axons and microtubule-associated protein 2C in cell bodies and dendrites contributes to polarized localization of cytoskeletal proteins in mature neurons, J. Cell Biol. 132 (1996) 667-679.
191. N. Hirokawa, Y. Shiomura, S. Okabe, Tau proteins: the molecular structure and mode of binding on microtubules, J. Cell Biol. 107 (1988) 1449-1459.
192. C. Hock, S. Golombowski, F. Muller-Spahn, O. Peschel, A. Riederer, A. Probst, E. Mandelkow, J. Unger, Histological markers in nasal mucosa of patients with Alzheimer's disease, Eur. Neurol. 40 (1998) 31-36.
193. C. Hock, S. Golombowski, W. Naser, F. Muller-Spahn, Increased levels of tau protein in cerebrospinal fluid of patients with Alzheimer's disease-correlation with degree of cognitive impairment, Ann. Neurol. 37 (1995) 414-415.
194. P.R. Hof, C. Bouras, L. Bueee, A. Delacourte, D.P. Perl, J.H. Morrison, Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer's disease cases, Acta Neuropathol. 85 (1992) 23-30.
195. P.R. Hof, C. Bouras, J.H. Morrison, Cortical neuropathology in aging and dementing disorders: neuronal typology, connectivity, and selective vulnerability, in: A. Peters, J.H. Morrison (Eds.), Cerebral Cortex, Vol. 14, Kluwer Academic Plenum, New York, 1999, pp. 175-312.
196. P.R. Hof, C. Bouras, D.P. Perl, J.H. Morrison, Quantitative neuropathologic analysis of Pick's disease cases: cortical distribution of Pick bodies and coexistence with Alzheimer's disease, Acta Neuropathol. 87 (1994) 115-124.
197. P.R. Hof, C. Bouras, D.P. Perl, D.L. Sparks, N. Mehta, J.H. Morrison, Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease, Arch. Neurol. 52 (1995) 379-391.
198. P.R. Hof, A. Charpiot, A. Delacourte, L. Bueee, D. Purohit, D.P. Perl, C. Bouras, Distribution of neurofibrillary tangles and senile plaques in the cerebral cortex in postencephalitic parkinsonism, Neurosci. Lett. 139 (1992) 10-14.
199. P.R. Hof, K. Cox, J.H. Morrison, Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex, J. Comp. Neurol. 301 (1990) 44-54.
200. P.R. Hof, A. Delacourte, C. Bouras, Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases, Acta Neuropathol. 84 (1992) 45-51.
201. P.R. Hof, J.H. Morrison, The cellular basis of cortical disconnection in Alzheimer disease and related dementing conditions, in: R.D. Terry, R. Katzman, K.L. Bick, S.S. Sisodia (Eds.), Alzheimer Disease, Lippincott Williams and Wilkins, Philadelphia, 1999, 207-232.
202. P.R. Hof, E.A. Nimchinsky, V. Buee-Scherrer, L. Buee, J. Nasrallah, A.F. Hottinger, D.P. Purohit, A.J. Loerzel, J.C. Steele, A. Delacourte, C. Bouras, J.H. Morrison, D.P. Perl, Amyotrophic lateral sclerosis /parkinsonism-dementia complex of Guam: quantitative neuropathology, immunohistochemical analysis of neuronal vulnerability, and comparison with related neurodegenerative disorders, Acta Neuropathol. 88 (1994) 397-404.
203. P.R. Hof, E.A. Nimchinsky, J.H. Morrison, Neurochemical pheno-type of corticocortical connections in the macaque monkey: quantitative analysis of a subset of neurofilament protein-immuno-reactive projection neurons in frontal, parietal, temporal, and cingulate cortices, J. Comp. Neurol. 362 (1995) 109-133.
204. P.R. Hof, D.P. Perl, A.J. Loerzel, J.H. Morrison, Neurofibrillary tangle distribution in the cerebral cortex of parkinsonism-dementia cases from Guam: differences with Alzheimer's disease, Brain Res. 564 (1991) 306-313.
205. R. Hoffmann, V.M.Y. Lee, S. Leight, I. Varga, L. Otvos Jr., Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites, Biochemistry 36 (1997) 8114-8124.
206. G.D. Holt, R.S. Haltiwanger, C.R. Torres, G.W. Hart, Erythrocytes contain cytoplasmic glycoproteins. O-linked GlcNAc on Band 4.1, J. Biol. Chem. 262 (1987) 14847-14850.
207. M. Holzer, H.P. Holzapfel, D. Zedlick, M.K. Bruckner, T. Arendt, Abnormally phosphorylated tau protein in Alzheimer's disease: heterogeneity of individual regional distribution and relationship to clinical severity, Neuroscience 63 (1994) 499-516.
208. M. Hong, V. Zhukareva, V. Vogelsberg-Ragaglia, Z. Wszolek, L. Reed, B.I. Miller, D.H. Geschwind, T.D. Bird, D. McKeel, A. Goate, J.C. Morris, K.C. Wilhelmsen, G.D. Schellenberg, J.Q. Trojanowski, VM.Y. Lee, Mutation-specific functional impairments in distinct tau isoforms ofhereditary FTDP-17, Science 282 (1998) 1914-1917.
209. F. Hulstaert, K. Blennow, A. Ivanoiu, H.C. Schoonderwaldt, M. Riemenschneider, P.P. De Deyn, C. Bancher, P. Cras, J. Wiltfang, P.D. Mehta, K. Iqbal, H. Pottel, E. Vanmechelen, H. Vanderstichele, Improved discrimination of AD patients using beta-amyloid(1 -42) and tau levels in CSF, Neurology 52 (1999) 1555-1562.
210. M. Hutton, C.L. Lendon, P. Rizzu, M. Baker, S. Froelich, H. Houlden, S. Pickering-Brown, S. Chakraverty, A. Isaacs, A. Grover, J. Hackett, J. Adamson, S. Lincoln, D. Dickson, P. Davies, R.C. Petersen, M. Stevens, E. de Graaff, E. Wauters, J. van Baren, M. Hillebrand, M. Joosse, J.M. Kwon, P. Nowotny, L.K. Che, J. Norton, J.C. Morris, L.A. Reed, J.Q. Trojanowski, H. Basun, L. Lannfelt, M. Neystat, S. Fahn, F. Dark, T. Tannenberg, P.R. Dodd, N. Hayward, J.B.J. Kwok, P.R. Schofield, A. Andreadis, J. Snow-den, D. Craufurd, D. Neary, F. Owen, B.A. Oostra, J. Hardy, A. Goate, J. van Swieten, D. Mann, T. Lynch, P. Heutink, Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17, Nature 393 (1998) 702-705.
211. S.C. Hwang, D.Y. Jhon, Y.S. Bae, J.H. Kim, S.G. Rhee, Activation of phospholipase C-gamma by the concerted action of tau proteins and arachidonic acid, J. Biol. Chem. 271 (1996) 18342-18349.
212. B.T. Hyman, J.Q. Trojanowski, Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease, J. Neuropathol. Exp. Neurol. 56 (1997) 10951097.
213. Y. Ihara, N. Nukina, R. Miura, M. Ogawara, Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer's disease, J. Biochem. 99 (1986) 1807-1810.
214. M. Iijima, T. Tabira, P. Poorkaj, G.D. Schellenberg, J.Q. Tro-janowski, V.M.Y. Lee, M.L. Schmidt, K. Takahashi, T. Nabika, T. Matsumoto, Y. Yamashita, S. Yoshioka, H. Ishino, A distinct familial presenile dementia with a novel missense mutation in the tau gene, NeuroReport 10 (1999) 497-501.
215. T.S. Ingebritsen, P. Cohen, Protein phosphatases: properties and role in cellular regulation, Science 221 (1983) 331-338.
216. M. Ingelson, E. Vanmechelen, L. Lannfelt, Microtubule-associated protein tau in human fibroblasts with the Swedish Alzheimer mutation, Neurosci. Lett. 220 (1996) 9-12.
217. I. Irminger-Finger, R.A. Laymon, L.S. Goldstein, Analysis of the primary sequence and microtubule-binding region of the Dro-sophila 205K MAP, J. Cell Biol. 111 (1990) 2563-2572.
218. T. Ishihara, M. Hong, B. Zhang, Y. Nakagawa, M.K. Lee, J.Q. Trojanowski, V.M. Lee, Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform, Neuron 24 (1999) 751-762.
219. H. Ishino, S. Otsuki, Frequency of Alzheimer's neurofibrillary tangles in the cerebral cortex in progressive supranuclear palsy (subcortical argyrophilic dystrophy), J. Neurol. Sci. 28 (1976) 309-316.
220. K. Isoe, K. Urakami, T. Shimomura, Y. Wakutani, Y. Ji, Y. Adachi, K. Takahashi, Tau proteins in cerebrospinal fluid from patients with Alzheimer's disease: a longitudinal study, Dementia 7 (1996) 175-176.
221. A. Jaspert, R. Fahsold, H. Grehl, D. Claus, Myotonic dystrophy: correlation of clinical symptoms with the size of the CTG trinucleotide repeat, J. Neurol. 242 (1995) 99-104.
222. S.M. Jenkins, G.V. Johnson, Tau complexes with phospholipase C-gamma in situ, NeuroReport 9 (1998) 67-71.
223. S.M. Jenkins, M. Zinnerman, C. Garner, G.V. Johnson, Modulation of tau phosphorylation and intracellular localization by cellular stress, Biochem. J. 345 (2000) 263-270.
224. M. Jensen, H. Basun, L. Lannfelt, Increased cerebrospinal fluid tau in patients with Alzheimer's disease, Neurosci. Lett. 186 (1995) 189-191.
225. G.A. Jicha, E. Lane, I. Vincent, L. Otvos Jr., R. Hoffmann, P. Davies, A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease, J. Neurochem. 69 (1997) 2087-2095.
226. G.A. Jicha, A. O'Donnell, C. Weaver, R. Angeletti, P. Davies, Hierarchical phosphorylation of recombinant tau by the paired-helical filament-associated protein kinase is dependent on cyclic AMP-dependent protein kinase, J. Neurochem. 72 (1999) 214-224.
227. G.V. Johnson, Differential phosphorylation of tau by cyclic AMP-dependent protein kinase and Ca21 /calmodulin-dependent protein kinase II: metabolic and functional consequences, J. Neurochem. 59 (1992) 2056-2062.
228. G.V. Johnson, P. Seubert, T.M. Cox, R. Motter, J.P. Brown, D. Galasko, The tau protein in human cerebrospinal fluid in Alzheimer's disease consists of proteolytically derived fragments, J. Neurochem. 68 (1997) 430-433.
229. T. Kampers, P. Friedhoff, J. Biernat, E.M. Mandelkow, E. Mandelkow, RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments, FEBS Lett. 399 (1996) 344-349.
230. M. Kanai, E. Matsubara, K. Isoe, K. Urakami, K. Nakashima, H. Arai, H. Sasaki, K. Abe, T. Iwatsubo, T. Kosaka, M. Watanabe, Y. Tomidokoro, M. Shizuka, K. Mizushima, T. Nakamura, Y. Igeta, Y. Ikeda, M. Amari, T. Kawarabayashi, K. Ishiguro, Y. Harigaya, K. Wakabayashi, K. Okamoto, S. Hirai, M. Shoji, Longitudinal study of cerebrospinal fluid levels of tau, Abeta 1-40, and Abeta 1-42(43) in Alzheimer's disease: a study in Japan, Ann. Neurol. 44 (1998) 17-26.
231. M.J. Kent, N.D. Light, A.J. Bailey, Evidence for glucose-mediated covalent cross-linking of collagen after glycosylation in vitro, Biochem. J. 225 (1985) 745-752.
232. M. Kidd, Paired helical filaments in electron microscopy of Alzheimer's disease, Nature 197 (1963) 192-193.
233. A. Kiuchi, N. Otsuka, Y. Namba, I. Nakano, M. Tomonaga, Presenile appearance of abundant Alzheimer's neurofibrillary tangles without senile plaques in the brain in myotonic dystrophy, Acta Neuropathol. 82 (1991) 1-5.
234. L.W. Ko, E.C. Ko, P. Nacharaju, W.K. Liu, E. Chang, A. Kenessey, S.H. Yen, An immunochemical study on tau glycation in paired helical filaments, Brain Res. 830 (1999) 301-313.
235. C.M. Kondratick, D.D. Vandre, Alzheimer's disease neurofibrillary tangles contain mitosis-specific phosphoepitopes, J. Neurochem. 67 (1996) 2405-2416.
236. A. Korneyev, L. Binder, J. Bernardis, Rapid reversible phosphorylation of rat brain tau proteins in response to cold water stress, Neurosci. Lett. 191 (1995) 19-22.
237. K.S. Kosik, E.A. Finch, MAP2 and tau segregate into dendritic and axonal domains after the elaboration of morphologically distinct neurites: an immunocytochemical study of cultured rat cerebrum, J. Neurosci. 7 (1987) 3142-3153.
238. K.S. Kosik, C.L. Joachim, D.J. Selkoe, Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease, Proc. Natl. Acad. Sci. USA 83 (1986) 4044-4048.
239. K.S. Kosik, N.W. Kowall, A. McKee, Along the way to a neurofibrillary tangle: a look at the structure of tau, Ann. Med. 21 (1989) 109-112.
240. K.S. Kosik, L.D. Orecchio, S. Bakalis, R.L. Neve, Developmentally regulated expression of specific tau sequences, Neuron 2 (1989) 1389-1397.
241. T. Kovacs, N.J. Cairns, P.L. Lantos, beta-amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer's disease, Neuropathol. Appl. Neurobiol. 25 (1999) 481-491.
242. L.K. Kreppel, M.A. Blomberg, G.W. Hart, Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats, J. Biol. Chem. 272 (1997) 9308-9315.
243. H. Ksiezak-Reding, W.K. Liu, S.H. Yen, Phosphate analysis and dephosphorylation of modified tau associated with paired helical filaments, Brain Res. 597 (1992) 209-219.
244. H. Ksiezak-Reding, K. Morgan, L.A. Mattiace, P. Davies, W.K. Liu, S.H. Yen, K. Weidenheim, D.W. Dickson, Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration, Am. J. Pathol. 145 (1994) 1496-1508.
245. Y. Kumagae, Y. Zhang, O.J. Kim, C.A. Miller, Human c-Jun N-terminal kinase expression and activation in the nervous system, Mol. Brain Res. 67 (1999) 10-17.
246. A. Kurz, M. Riemenschneider, K. Buch, F. Willoch, P. Bartenstein, U. Muller, W. Guder, Tau protein in cerebrospinal fluid is significantly increased at the earliest clinical stage of Alzheimer disease, Alzheimer Dis. Assoc. Disord. 12 (1998) 372-377.
247. C.J. Ladner, J. Czech, J. Maurice, S.A. Lorens, J.M. Lee, Reduction of calcineurin enzymatic activity in Alzheimer's disease: correlation with neuropathologic changes, J. Neuropathol. Exp. Neurol. 55 (1996) 924-931.
248. M.D. Ledesma, P. Bonay, J. Avila, Tau protein from Alzheimer's disease patients is glycated at its tubulin-binding domain, J. Neurochem. 65 (1995) 1658-1664.
249. G. Lee, N. Cowan, M. Kirschner, The primary structure and heterogeneity of tau protein from mouse brain, Science 239 (1988) 285-288.
250. G. Lee, S.L. Kwei, S.T. Newman, M. Lu, Y. Liu, A new molecular interactor for tau protein, Soc. Neurosci. Abstr. 22 (1996) 975.
251. G. Lee, R.L. Neve, K.S. Kosik, The microtubule binding domain of tau protein, Neuron 2 (1989) 1615-1624.
252. G. Lee, S.T. Newman, D.L. Gard, H. Band, G. Panchamoorthy, Tau interacts with src-family non-receptor tyrosine kinases, J. Cell Sci. 111 (1998) 3167-3177.
253. G. Lee, S.L. Rook, Expression oftau protein in non-neuronal cells: microtubule binding and stabilization, J. Cell Sci. 102 (1992) 227-237.
254. J.H. Lee, M. Goedert,W.D. Hill, V.M.Y. Lee, J.Q. Trojanowski, Tau proteins are abnormally expressed in olfactory epithelium of Alzheimer patients and developmentally regulated in human fetal spinal cord, Exp. Neurol. 121 (1993) 93-105.
255. V.M.Y. Lee, B.J. Balin, L. Otvos Jr., J.Q. Trojanowski, A68: a major subunit of paired helical filaments and derivatized forms of normal Tau, Science 251 (1991) 675-678.
256. T. Lefebvre, C. Alonso, S. Mahboub, M.J. Dupire, J.P. Zanetta, M.L. Caillet-Boudin, J.C. Michalski, Effect of okadaic acid on O-linked W-acetylglucosamine levels in a neuroblastoma cell line, Biochim Biophys Acta 1472 (1999) 71-81.
257. J.F. Leterrier, R.K. Liem, M.L. Shelanski, Interactions between neurofilaments and microtubule-associated proteins: a possible mechanism for intraorganellar bridging, J. Cell Biol. 95 (1982) 982-986.
258. H. Liao, Y. Li, D.L. Brautigan, G.G. Gundersen, Protein phospha-tase 1 is targeted to microtubules by the microtubule-associated protein Tau, J. Biol. Chem. 273 (1998) 21901-21908.
259. G. Lindwall, R.D. Cole, Phosphorylation affects the ability of tau protein to promote microtubule assembly, J. Biol. Chem. 259 (1984) 5301-5305.
260. J.M. Litersky, G.V. Johnson, Phosphorylation by cAMP-dependent protein kinase inhibits the degradation of tau by calpain, J. Biol. Chem. 267 (1992) 1563-1568.
261. I. Litvan, The clinical and pathologic hallmarks of progressive supranuclear palsy, Curr. Opin. Neurol. 10 (1997) 346-350.
262. I. Litvan, Y. Agid, J. Jankovic, C. Goetz, J.P. Brandel, E.C. Lai, G. Wenning, L. D'Olhaberriague, M. Verny, K.R. Chaudhuri, A. McKee, K. Jellinger, J.J. Bartko, C.A. Mangone, R.K. Pearce, Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome), Neurology 46 (1996) 922-930.
263. I. Litvan, J.J. Hauw, J.J. Bartko, P.L. Lantos, S.E. Daniel, D.S. Horoupian, A. McKee, D. Dickson, C. Bancher, M. Tabaton, K. Jellinger, D.W. Anderson, Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders, J. Neuropathol. Exp. Neurol. 55 (1996) 97-105.
264. W.K. Liu, R.T. Williams, F.L. Hall, D.W. Dickson, S.H. Yen, Detection of a Cdc2-related kinase associated with Alzheimer paired helical filaments, Am. J. Pathol. 146 (1995) 228-238.
265. Y. Liu, J. Xia, D. Ma, D.S. Faber, I. Fischer, Tau-like proteins in the nervous system of goldfish, Neurochem. Res. 22 (1997) 15111516.
266. S.K. Loftus, J.A. Morris, E.D. Carstea, J.Z. Gu, C. Cummings, A. Brown, J. Ellison, K. Ohno, M.A. Rosenfeld, D.A. Tagle, P.G. Pentchev, W.J. Pavan, Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene, Science 277 (1997) 232-235.
267. S. Love, L.R. Bridges, C.P. Case, Neurofibrillary tangles in Niemann-Pick disease type C, Brain 118 (1995) 119-129.
268. S. Lovestone, C.H. Reynolds, The phosphorylation oftau: a critical stage in neurodevelopment and neurodegenerative processes, Neuroscience 78 (1997) 309-324.
269. T. Lynch, M. Sano, K.S. Marder, K.L. Bell, N.L. Foster, R.F. Defendini, A.A. Sima, C. Keohane, T.G. Nygaard, S. Fahn, R. Mayeux, L.P. Rowland, K.C. Wilhemsen, Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-par-kinsonism-amyotrophy complex, Neurology 44 (1994) 1878-1884.
270. C. Mailliot, T. Bussiere, M.L. Caillet-Boudin, A. Delacourte, L. Buee, Alzheimer-specific epitope of AT100 in transfected cell lines with tau: toward an efficient cell model of tau abnormal phosphorylation, Neurosci. Lett. 255 (1998) 13-16.
271. C. Mailliot, V. Podevin-Dimster, R. Rosenthal, N. Sergeant, A. Delacourte, G. Fiskum, L. Buee, Rapid tau dephosphorylation and rephosphorylation during cadiac arrest-induced cerebral ischemia and reperfusion, J. Cereb. Blood Flow Metab. 2000, in press.
272. C. Mailliot, N. Sergeant, T. Bussiere, M.L. Caillet-Boudin, A. Delacourte, L. Buee, Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes, FEBS Lett. 433 (1998) 201-204.
273. A. Malandrini, T. Cavallaro, G.M. Fabrizi, G. Berti, R. Salvestroni, C. Salvadori, G.C. Guazzi, Ultrastructure and immunoreactivity of dystrophic axons indicate a different pathogenesis of Hallervor-den-Spatz disease and infantile neuroaxonal dystrophy, Virchows Arch. 427 (1995) 415-421.
274. J.W. Mandell, G.A. Banker, The microtubule cytoskeleton and the development of neuronal polarity, Neurobiol. Aging 16 (1995) 229-237.
275. D.M.A. Mann, A. Brown, D. Prinja, C.A. Davies, M. Landon, C.L. Masters, K. Beyreuthers, An analysis of the morphology of senile plaques in Down's syndrome patients of different ages using immunocytochemical and lectin histochemical techniques, Neuro-pathol. Appl. Neurobiol. 15 (1989) 317-329.
276. D.M.A. Mann, P.O. Yates, B. Marcyniuk, Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes, Neuropathol. Appl. Neurobiol. 10 (1984) 185-207.
277. E.S. Matsuo, R.W. Shin, M.L. Billingsley, A. Van deVoorde, M. O'Connor, J.Q. Trojanowski, V.M.Y. Lee, Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau, Neuron 13 (1994) 989-1002.
278. L.A. Mattiace, E. Wu, M. Aronson, D.W. Dickson, A new neuritic plaque without amyloid in corticonigral degeneration with neuronal achromasia, J. Neuropathol. Exp. Neurol. 50 (1991) 310.
279. A. Matus, Stiff microtubules and neuronal morphology, Trends Neurosci. 17 (1994) 19-22.
280. M. Mawal-Dewan, J. Henley, A. Van de Voorde, J.Q. Trojanowski, V.M.Y. Lee, The phosphorylation state of tau in the developing rat brain is regulated by phosphoprotein phosphatases, J. Biol. Chem. 269 (1994) 30981-30987.
281. J.B. McDermott, S. Aamodt, E. Aamodt, ptl-1, a Caenorhabditis elegans gene whose products are homologous to the tau micro-tubule-associated proteins, Biochemistry 35 (1996) 9415-9423.
282. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, E.M. Stadlan, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology 34 (1984) 939-944.
283. S. McQuaid, I.V. Allen, J. McMahon, J. Kirk, Association of measles virus with neurofibrillary tangles in subacute sclerosing panencephalitis: a combined in situ hybridization and immuno-cytochemical investigation, Neuropathol. Appl. Neurobiol. 20 (1994) 103-110.
284. M.L. Miller, G.V. Johnson, Transglutaminase cross-linking of the tau protein, J. Neurochem. 65 (1995) 1760-1770.
285. Y. Miyata, M. Hoshi, E. Nishida, Y. Minami, H. Sakai, Binding of microtubule-associated protein 2 and tau to the intermediate filament reassembled from neurofilament 70 kDa subunit protein. Its regulation by calmodulin, J. Biol. Chem. 261 (1986) 1302613030.
286. A.A. Mohit, J.H. Martin, C.A. Miller, p493F12 kinase: a novel MAP kinase expressed in a subset of neurons in the human nervous system, Neuron 14 (1995) 67-78.
287. H. Mori, K. Hosoda, E. Matsubara, T. Nakamoto, Y. Furiya, R. Endoh, M. Usami, M. Shoji, S. Maruyama, S. Hirai, Tau in cerebrospinal fluids: establishment of the sandwich ELISA with antibody specific to the repeat sequence in tau, Neurosci. Lett. 186 (1995) 181-183.
288. H. Mori, J. Kondo, Y. Ihara, Ubiquitin is a component of paired helical filaments in Alzheimer's disease, Science 235 (1987) 1641-1644.
289. M. Morishima-Kawashima, M. Hasegawa, K. Takio, M. Suzuki, K. Titani, Y. Ihara, Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments, Neuron 10 (1993) 1151-1160.
290. M. Morishima-Kawashima, M. Hasegawa, K. Takio, M. Suzuki, H. Yoshida, K. Titani, Y. Ihara, Proline-directed and non-proline-directed phosphorylation of PHF-tau, J. Biol. Chem. 270 (1995) 823-829.
291. H.R. Morris, J.C. Janssen, O. Bandmann, S.E. Daniel, M.N. Rossor, A.J. Lees, N.W. Wood, The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases, J. Neurol. Neurosurg. Psychiatry 66 (1999) 665-667.
292. R. Motter, C. Vigo-Pelfrey, D. Kholodenko, R. Barbour, K. Johnson-Wood, D. Galasko, L. Chang, B. Miller, C. Clark, R. Green, D. Olson, P. Southwick, R. Wolfert, B. Munroe, I. Lieber-burg, P. Seubert, D. Schenk, Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease, Ann. Neurol. 38 (1995) 643-648.
293. S.F. Mulot, K. Hughes, J.R. Woodgett, B.H. Anderton, D.P. Hanger, PHF-tau from Alzheimer's brain comprises four species on SDS-PAGE which can be mimicked by in vitro phosphorylation of human brain tau by glycogen synthase kinase-3 beta, FEBS Lett. 349 (1994) 359-364.
294. W.A. Munroe, P.C. Southwick, L. Chang, D.W. Scharre, C.L. Echols Jr., P.C. Fu, J.M. Whaley, R.L. Wolfert, Tau protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer's disease, Ann. Clin. Lab. Sci. 25 (1995) 207-217.
295. J.R. Murrell, D. Koller, T. Foroud, M. Goedert, M.G. Spillantini, H.J. Edenberg, M.R. Farlow, B. Ghetti, Familial multiple-system tauopathy with presenile dementia is localized to chromosome 17, Am. J. Hum. Genet. 61 (1997) 1131-1138.
296. J.R. Murrell, M.G. Spillantini, P. Zolo, M. Guazzelli, M.J. Smith, M. Hasegawa, F. Redi, R.A. Crowther, P. Pietrini, B. Ghetti, M. Goedert, Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits, J. Neuropathol. Exp. Neurol. 58 (1999) 1207-1226.
297. P. Nacharaju, L. Ko, S.H. Yen, Characterization of in vitro glycation sites of tau, J. Neurochem. 69 (1997) 1709-1719.
298. Y. Namba, M. Tomonaga, H. Kawasaki, E. Otomo, K. Ikeda, Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease, Brain Res. 541 (1991) 163-166.
299. P.T. Nelson, K. Stefansson, J. Gulcher, C.B. Saper, Molecular evolution of tau protein: implications for Alzheimer's disease, J. Neurochem. 67 (1996) 1622-1632.
300. R.L. Neve, P. Harris, K.S. Kosik, D.M. Kurnit, T.A. Donlon, Identification of cDNA clones for the human microtubule-associ-ated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2, Brain Res. 387 (1986) 271-280.
301. R.A. Nixon, R.K. Sihag, Neurofilament phosphorylation: a new look at regulation and function, Trends Neurosci. 14 (1991 ) 501-506.
302. M.A. Norlund, J.M. Lee, G.M. Zainelli, N.A. Muma, Elevated transglutaminase-induced bonds in PHF tau in Alzheimer's disease, Brain Res. 851 (1999) 154-163.
303. M. Novak, Truncated tau protein as a new marker for Alzheimer's disease, Acta Virol. 38 (1994) 173-189.
304. R. Oliva, E. Tolosa, M. Ezquerra, J.L. Molinuevo, F. Valldeoriola, J. Burguera, M. Calopa, M. Villa, F. Ballesta, Significant changes in the tau A0 and A3 alleles in progressive supranuclear palsy and improved genotyping by silver detection, Arch. Neurol. 55 (1998) 1122-1124.
305. S. Ono, K. Inoue, T. Mannen, F. Kanda, K. Jinnai, K. Takahashi, Neuropathological changes of the brain in myotonic dystrophy-some new observations, J. Neurol. Sci. 81 (1987) 301-320.
306. T. Ono, H. Yamamoto, K. Tashima, H. Nakashima, E. Okumura, K. Yamada, S. Hisanaga, T. Kishimoto, T. Miyakawa, E. Miyamoto, Dephosphorylation of abnormal sites of tau factor by protein phosphatases and its implication for Alzheimer's disease, Neuro-chem. Int. 26 (1995) 205-215.
307. K. Oyanagi, T. Makifuchi, T. Ohtoh, K.M. Chen, T. van der Schaaf, D.C. Gajdusek, T.N. Chase, F. Ikuta, Amyotrophic lateral sclerosis of Guam: the nature of the neuropathological findings, Acta Neuropathol. 88 (1994) 405-412.
308. K. Oyanagi, T. Makifuchi, T. Ohtoh, F. Ikuta, K.M. Chen, T.N. Chase, D.C. Gajdusek, Topographic investigation of brain atrophy in parkinsonism-dementia complex of Guam: a comparison with Alzheimer's disease and progressive supranuclear palsy, Neurode-generation 3 (1994) 301-304.
309. D. Panda, B.L. Goode, S.C. Feinstein, L. Wilson, Kinetic stabilization of microtubule dynamics at steady state by tau and micro-tubule-binding domains of tau, Biochemistry 34 (1995) 11117-11127.
310. S.C. Papasozomenos, Heat shock induces rapid dephosphorylation of tau in both female and male rats followed by hyperphosphoryla-tion only in female rats: implications for Alzheimer's disease, J. Neurochem. 66 (1996) 1140-1149.
311. S.C. Papasozomenos, The heat shock-induced hyperphosphoryla-tion of tau is estrogen-independent and prevented by androgens: implications for Alzheimer disease, Proc. Natl. Acad. Sci. USA 94 (1997) 6612-6617.
312. P. Pastor, M. Ezquerra, E. Munoz, M.J. Marti, R. Blesa, E. Tolosa, R. Oliva, Significant association between the tau gene A0/A0 genotype and Parkinson's disease, Ann. Neurol. 47 (2000) 242-245.
313. H.K. Paudel, W. Li, Heparin-induced conformational change in microtubule-associated protein Tau as detected by chemical cross-linking and phosphopeptide mapping, J. Biol. Chem. 274 (1999) 8029-8038.
314. W. Paulus, M. Selim, Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles, Acta Neuropathol. 81 (1990) 89-94.
315. M. Perez, J.M. Valpuesta, M. Medina, E. Montejo de Garcini, J. Avila, Polymerization of tau into filaments in the presence of heparin: the minimal sequence required for tau-tau interaction, J. Neurochem. 67 (1996) 1183-1190.
316. J. Perez-Tur, L. Buee, H.R. Morris, S.C. Waring, L. Onstead, F. Wavrant-De Vrieze, R. Crook, V. Buee-Scherrer, P.R. Hof, R.C. Petersen, P.L. McGeer, A. Delacourte, M. Hutton, T. Siddique, J.E. Ahlskog, J. Hardy, J.C. Steele, Neurodegenerative diseases of Guam: analysis of TAU, Neurology 53 (1999) 411-413.
317. D.P. Perl, A.R. Brody, Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons, Science 208 (1980) 297-299.
318. D.P. Perl, P.F. Good, Aluminum, Alzheimer's disease, and the olfactory system, Ann. N.Y. Acad. Sci. 640 (1991) 8-13.
319. S. Pickering-Brown, H. Houlden, M. Baker, J. Adamson, F. Owen, D. Neary, D. Craufurd, J. Snowden, D. Mann, M. Hutton, Pick's Disease is associated with mutations in the tau gene, submitted
320. J. Poirier, A. Minnich, J. Davignon, Apolipoprotein E, synaptic plasticity and Alzheimer's disease, Ann. Med. 27 (1995) 663-670.
321. N.J. Pollock, S.S. Mirra, L.I. Binder, L.A. Hansen, J.G. Wood, Filamentous aggregates in Pick's disease, progressive supranuclear palsy, and Alzheimer's disease share antigenic determinants with microtubule-associated protein tau, Lancet 2 (1986) 1211.
322. P. Poorkaj, T.D. Bird, E. Wijsman, E. Nemens, R.M. Garruto, L. Anderson, A. Andreadis, W.C. Wiederholt, M. Raskind, G.D. Schellenberg, Tau is a candidate gene for chromosome 17 fron-totemporal dementia, Ann. Neurol. 43 (1998) 815-825, Published erratum appears in Ann. Neurol. 44 (1998) 1428.
323. W. Pope, S.A. Enam, N. Bawa, B.E. Miller, H.A. Ghanbari, W.L. Klein, Phosphorylated tau epitope of Alzheimer's disease is coupled to axon development in the avian central nervous system, Exp. Neurol. 120 (1993) 106-113.
324. A. Probst, D. Langui, C. Lautenschlager, J. Ulrich, J.P. Brion, B.H. Anderton, Progressive supranuclear palsy: extensive neuropil threads in addition to neurofibrillary tangles. Very similar an-tigenicity of subcortical neuronal pathology in progressive supranu-clear palsy and Alzheimer's disease, Acta Neuropathol. 77 (1988) 61-68.
325. A. Probst, M. Tolnay, D. Langui, M. Goedert, M.G. Spillantini, Pick's disease: hyperphosphorylated tau protein segregates to the somatoaxonal compartment, Acta Neuropathol. 92 (1996) 588596.
326. J.J. Rebeiz, E.H. Kolodny, E.P. Richardson Jr., Corticodentatonigr-al degeneration with neuronal achromasia, Arch. Neurol. 18 (1968) 20-33.
327. M. Rebhan, G. Vacun, H. Rosner, Complementary distribution of tau proteins in different phosphorylation states within growing axons, NeuroReport 6 (1995) 429-432.
328. L.A. Reed, M.L. Schmidt, Z.K. Wszolek, B.J. Balin, V Soontornniyomkij, V.M.Y. Lee, J.Q. Trojanowski, R.L. Schelper, The neuropathology of a chromosome 17-linked autosomal dominant parkinsonism and dementia ('pallido-ponto-nigral degeneration'), J. Neuropathol. Exp. Neurol. 57 (1998) 588-601.
329. A. Rendon, D. Jung, V. Jancsik, Interaction of microtubules and microtubule-associated proteins (MAPs) with rat brain mitochondria, Biochem. J. 269 (1990) 555-556.
330. N.B. Rewcastle, Degenerative diseases of the central nervous system, in: R.L. Davis, D.M. Robertson (Eds.), Textbook of Neuropathology, Williams and Wilkins, Baltimore, 1991, 903-961.
331. P.F. Reyes, D.A. Deems, M.G. Suarez, Olfactory-related changes in Alzheimer's disease: a quantitative neuropathologic study, Brain Res. Bull. 32 (1993) 1-5.
332. C.H. Reynolds, M.A. Utton, G.M. Gibb, A. Yates, B.H. Anderton, Stress-activated protein kinase /c-jun N-terminal kinase phos-phorylates tau protein, J. Neurochem. 68 (1997) 1736-1744.
333. B.M. Riederer, L.I. Binder, Differential distribution of tau proteins in developing cat cerebellum, Brain Res. Bull. 33 (1994) 155-161.
334. M. Riemenschneider, K. Buch, M. Schmolke, A. Kurz, W.G. Guder, Cerebrospinal protein tau is elevated in early Alzheimer's disease, Neurosci. Lett. 212 (1996) 209-211.
335. J.O. Rinne, M.S. Lee, P.D. Thompson, C.D. Marsden, Corticobasal degeneration. A clinical study of 36 cases, Brain 117 (1994) 1183-1196.
336. P. Rizzu, J.C. Van Swieten, M. Joosse, M. Hasegawa, M. Stevens, A. Tibben, M.F. Niermeijer, M. Hillebrand, R. Ravid, B.A. Oostra, M. Goedert, C.M. van Duijn, P. Heutink, High prevalence of mutations in the microtubule- associated protein tau in a population study of frontotemporal dementia in the Netherlands, Am. J. Hum. Genet. 64 (1999) 414-421.
337. W.A. Rocca, A. Hofman, C. Brayne, M.M. Breteler, M. Clarke, J.R. Copeland, J.F. Dartigues, K. Engedal, O. Hagnell, T.J. Heeren, C. Jonker, J. Lindesay, A. Lobo, A.H. Mann, P.K. Molsa, M. K., D. W. O'Connor, A. Da Silva Droux, R. Sulkava, D.W.K. Kay, L. Amaducci, Frequency and distribution of Alzheimer's disease in Europe: a collaborative study of 1980-1990 prevalence findings. The EURODEM-Prevalence Research Group, Ann. Neurol. 30 (1991) 381-390.
338. H.M. Roder, R.P. Fracasso, F.J. Hoffman, J.A. Witowsky, G. Davis, C.B. Pellegrino, Phosphorylation-dependent monoclonal Tau antibodies do not reliably report phosphorylation by extracellular signal-regulated kinase 2 at specific sites, J. Biol. Chem. 272 (1997) 4509-4515.
339. R.E. Rosenthal, R. Williams, Y.E. Bogaert, P.R. Getson, G. Fiskum, Prevention of postischemic canine neurological injury through potentiation of brain energy metabolism by acetyl-L-carnitine, Stroke 23 (1992) 1312-1317.
340. H. Rosner, M. Rebhan, G. Vacun, E. Vanmechelen, Developmental expression of tau proteins in the chicken and rat brain: rapid down-regulation of a paired helical filament epitope in the rat cerebral cortex coincides with the transition from immature to adult tau isoforms, Int. J. Dev. Neurosci. 13 (1995) 607-617.
341. E. Sadot, A. Heicklen-Klein, J. Barg, P. Lazarovici, I. Ginzburg, Identification of a tau promoter region mediating tissue-specific-regulated expression in PC12 cells, J. Mol. Biol. 256 (1996) 805-812, Published erratum appears in J. Mol. Biol. 258 (1996) 1539.
342. T. Saito, K. Ishiguro, T. Uchida, E. Miyamoto, T. Kishimoto, S. Hisanaga, In situ dephosphorylation of tau by protein phosphatase 2A and 2B in fetal rat primary cultured neurons, FEBS Lett. 376 (1995) 238-242.
343. N. Sasaki, R. Fukatsu, K. Tsuzuki, Y. Hayashi, T. Yoshida, N. Fujii, T. Koike, I. Wakayama, R. Yanagihara, R. Garruto, N. Amano, Z. Makita, Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases, Am. J. Pathol. 153 (1998) 1149-1155.
344. R.F. Sattilaro, W.L. Dentler, E.L. LeCluyse, Microtubule-associated proteins (MAPs) and the organization of actin filaments in vitro, J. Cell Biol. 90 (1981) 467-473.
345. A. Sawa, F. Oyama, M. Matsushita, Y. Ihara, Molecular diversity at the carboxyl terminus of human and rat tau, Mol. Brain Res. 27 (1994) 111-117.
346. M.L. Schmidt, R. Huang, J.A. Martin, J. Henley, M. Mawal-Dewan, H.I. Hurtig, VM.Y. Lee, J.Q. Trojanowski, Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau, J. Neuropathol. Exp. Neurol. 55 (1996) 534-539.
347. T.A. Schoenfeld, R.A. Obar, Diverse distribution and function of fibrous microtubule-associated proteins in the nervous system, Int. Rev. Cytol. 151 (1994) 67-137.
348. A. Schumacher, O. Lichtarge, S. Schwartz, T. Magnuson, The murine Polycomb-group gene eed and its human orthologue: functional implications of evolutionary conservation, Genomics 54 (1998) 79-88.
349. O. Schweers, E.M. Mandelkow, J. Biernat, E. Mandelkow, Oxidation of cysteine-322 in the repeat domain ofmicrotubule-associated protein tau controls the in vitro assembly of paired helical filaments, Proc. Natl. Acad. Sci. USA 92 (1995) 8463-8467.
350. C.W. Scott, A. Fieles, L.A. Sygowski, C.B. Caputo, Aggregation of tau protein by aluminum, Brain Res. 628 (1993) 77-84.
351. S.C. Selden, T.D. Pollard, Phosphorylation of microtubule-associated proteins regulates their interaction with actin filaments, J. Biol. Chem. 258 (1983) 7064-7071.
352. N. Sergeant, T. Bussieere, P. Vermersch, J.P. Lejeune, A. Delacourte, Isoelectric point differentiates PHF-tau from biopsy-derived human brain tau proteins, NeuroReport 6 (1995) 2217-2220.
353. N. Sergeant, J.P. David, M. Goedert, R. Jakes, P. Vermersch, L. Bueee, D. Lefranc, A. Wattez, A. Delacourte, Two-dimensional characterization of paired helical filament-tau from Alzheimer's disease: demonstration of an additional 74 kDa component and age-related biochemical modifications, J. Neurochem. 69 (1997) 834-844.
354. N. Sergeant, J.P. David, D. Lefranc, P. Vermersch, A. Wattez, A. Delacourte, Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases, FEBS Lett. 412 (1997) 578-582.
355. N. Sergeant, A. Wattez, A. Delacourte, Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively 'exon 10' isoforms, J. Neurochem. 72 (1999) 1243-1249.
356. P. Seubert, M. Mawal-Dewan, R. Barbour, R. Jakes, M. Goedert, G.V. Johnson, J.M. Litersky, D. Schenk, I. Lieberburg, J.Q. Trojanowski, V.M.Y. Lee, Detection of phosphorylated Ser262 in fetal tau, adult tau, and paired helical filament tau, J. Biol. Chem. 270 (1995) 18917-18922.
357. D.A. Shackelford, K.E. Nelson, Changes in phosphorylation of tau during ischemia and reperfusion in the rabbit spinal cord, J. Neurochem. 66 (1996) 286-295.
358. R.W. Shin, Interaction of aluminum with paired helical filament tau is involved in neurofibrillary pathology of Alzheimer's disease, Gerontology 43 (1997) 16-23.
359. J. Simon, D. Bornemann, K. Lunde, C. Schwartz, The extra sex combs product contains WD40 repeats and its time of action implies a role distinct from other Polycomb group products, Mech. Dev. 53 (1995) 197-208.
360. T.J. Singh, T. Zaidi, I. Grundke-Iqbal, K. Iqbal, Non-proline-dependent protein kinases phosphorylate several sites found in tau from Alzheimer disease brain, Mol. Cell. Biochem. 154 (1996) 143-151.
361. I. Skoog, E. Vanmechelen, L.A. Andreasson, B. Palmertz, P. Davidsson, C. Hesse, K. Blennow, A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele, Neurodegeneration 4 (1995) 433-442.
362. M.A. Smith, S.L. Siedlak, P.L. Richey, R.H. Nagaraj, A. Elhammer, G. Perry, Quantitative solubilization and analysis of insoluble paired helical filaments from Alzheimer disease, Brain Res. 717 (1996) 99-108.
363. M.A. Smith, S. Taneda, P.L. Richey, S. Miyata, S.D. Yan, D. Stern, L.M. Sayre, V.M. Monnier, G. Perry, Advanced Maillard reaction end products are associated with Alzheimer disease pathology, Proc. Natl. Acad. Sci. USA 91 (1994) 5710-5714, Published erratum appears in Proc. Natl. Acad. Sci. USA 92 (1995) 2016.
364. A.D. Snow, M.G. Kinsella, E. Parks, R.T. Sekiguchi, J.D. Miller, K. Kimata, T.N. Wight, Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease, Arch. Biochem. Biophys. 320 (1995) 84-95.
365. A.D. Snow, H. Mar, D. Nochlin, H. Kresse, T.N. Wight, Peripheral distribution of dermatan sulfate proteoglycans (decorin) in amyloid-containing plaques and their presence in neurofibrillary tangles of Alzheimer's disease, J. Histochem. Cytochem. 40 (1992) 105-113.
366. A.D. Snow, J.P. Willmer, R. Kisilevsky, Sulfated glycosamino-glycans in Alzheimer's disease, Hum. Pathol. 18 (1987) 506-510.
367. J. Song, C.K. Combs, W.H. Pilcher, L.Y. Song, A.K. Utal, P.D. Coleman, Low initial tau phosphorylation in human brain biopsy samples, Neurobiol. Aging 18 (1997) 475-481.
368. E. Sontag, V. Nunbhakdi-Craig, G.S. Bloom, M.C. Mumby, A novel pool of protein phosphatase 2A is associated with micro-tubules and is regulated during the cell cycle, J. Cell Biol. 128 (1995) 1131-1144.
369. E. Sontag,V. Nunbhakdi-Craig, G. Lee, R. Brandt, C. Kamibayashi, J. Kuret, C.L. White 3rd, M.C. Mumby, G.S. Bloom, Molecular Interactions among Protein Phosphatase 2A, Tau, and Micro-tubules. Implications for the regulation of tau phosphorylation and the development of tauopathies, J. Biol. Chem. 274 (1999) 2549025498.
370. C. Souliee, J. Lepagnol, A. Delacourte, M.L. Caillet-Boudin, Dephosphorylation studies of SKNSH-SY 5Y cell Tau proteins by endogenous phosphatase activity, Neurosci. Lett. 206 (1996) 189-192.
371. M.G. Spillantini, T.D. Bird, B. Ghetti, Frontotemporal dementia and parkinsonism linked to chromosome 17: a new group of tauopathies, Brain Pathol. 8 (1998) 387-402.
372. M.G. Spillantini, R.A. Crowther, W. Kamphorst, P. Heutink, J.C. van Swieten, Tau pathology in two Dutch families with mutations in the microtubule-binding region oftau, Am. J. Pathol. 153 (1998) 1359-1363.
373. M.G. Spillantini, J.R. Murrell, M. Goedert, M.R. Farlow, A. Klug, B. Ghetti, Mutation in the tau gene in familial multiple system tauopathy with presenile dementia, Proc. Natl. Acad. Sci. USA 95 (1998) 7737-7741.
374. M.G. Spillantini, M.L. Schmidt, V.M.Y. Lee, J.Q. Trojanowski, R. Jakes, M. Goedert, Alpha-synuclein in Lewy bodies, Nature 388 (1997) 839-840.
375. M.G. Spillantini, M. Tolnay, S. Love, M. Goedert, Microtubule-associated protein tau, heparan sulphate and alpha-synuclein in several neurodegenerative diseases with dementia, Acta Neuropathol. 97 (1999) 585-594.
376. K. Spittaels, C. Van den Haute, J. Van Dorpe, K. Bruynseels, K. Vandezande, I. Laenen, H. Geerts, M. Mercken, R. Sciot, A. Van Lommel, R. Loos, F. Van Leuven, Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein, Am. J. Pathol. 155 (1999) 2153-2165.
377. J.C. Steele, J. Richardson, J. Olszewski, Progressive supranuclear palsy. A heterogeneous degeneration involving brain stem, basal ganglia and cerebellum with vertical gaze ans pseudobulbar palsy, nuchal dystonia and dementia, Arch. Neurol (1964) 333-359.
378. W.J. Strittmatter, A.M. Saunders, M. Goedert, K.H. Weisgraber, L.M. Dong, R. Jakes, D.Y. Huang, M. Pericak-Vance, D. Schmech-el, A.D. Roses, Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease, Proc. Natl. Acad. Sci. USA 91 (1994) 11183-11186.
379. G.I. Szendrei,V.M.Y. Lee, L. Otvos Jr., Recognition ofthe minimal epitope of monoclonal antibody Tau-1 depends upon the presence of a phosphate group but not its location, J. Neurosci. Res. 34 (1993) 243-249.
380. M. Takahashi, K. Tomizawa, K. Ishiguro, M. Takamatsu, S.C. Fujita, K. Imahori, Involvement of tau protein kinase I in paired helical filament-like phosphorylation of the juvenile tau in rat brain, J. Neurochem. 64 (1995) 1759-1768.
381. A. Takashima, M. Murayama, O. Murayama, T. Kohno, T. Honda, K. Yasutake, N. Nihonmatsu, M. Mercken, H. Yamaguchi, S. Sugihara, B. Wolozin, Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau, Proc. Natl. Acad. Sci. USA 95 (1998) 9637-9641.
382. B.R. Talamo, W.H. Feng, M. Perez-Cruet, L. Adelman, K. Kosik, V.M.Y. Lee, L.C. Cork, J.S. Kauer, Pathologic changes in olfactory neurons in Alzheimer's disease, Ann. N.Y. Acad. Sci. 640 (1991) 1-7.
383. B.R. Talamo, R. Rudel, K.S. Kosik, V.M.Y. Lee, S. Neff, L. Adelman, J.S. Kauer, Pathological changes in olfactory neurons in patients with Alzheimer's disease, Nature 337 (1989) 736-739.
384. I. Tellez-Nagel, H.M. Wisniewski, Ultrastructure of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome, Arch. Neurol. 29 (1973) 324-327.
385. V.C. Thurston, R.P. Zinkowski, L.I. Binder, Tau as a nucleolar protein in human nonneural cells in vitro and in vivo, Chromosoma 105 (1996) 20-30.
386. R. Tissot, J. Constantinidis, Pick's disease, in: J.A.M. Frederiks ( Ed.), Neurobehavioural Disorders, Handbook of Clinical Neurology, Vol. 46, Elsevier, Amsterdam, 1985, pp. 233-246.
387. M. Tolnay, A. Probst, Tau protein pathology in Alzheimer's disease and related disorders, Neuropathol. Appl. Neurobiol 25 (1999) 171-187.
388. B.E. Tomlinson, G. Blessed, M. Roth, Observations on the brains of non-demented old people, J. Neurol. Sci. 7 (1968) 331-356.
389. M. Tomonaga, Ultrastructure of neurofibrillary tangles in progressive supranuclear palsy, Acta Neuropathol. 37 (1977) 177-181.
390. C. Tranchant, N. Sergeant, A. Wattez, M. Mohr, J.M. Warter, A. Delacourte, Neurofibrillary tangles in Gerstmann-Straussler-Scheinker syndrome with the A117V prion gene mutation, J. Neurol. Neurosurg. Psychiatry 63 (1997) 240-246.
391. J.Q. Trojanowski, V.M.Y. Lee, Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: focusing on phosphatases, FASEB J. 9 (1995) 1570-1576.
392. J. Tucholski, J. Kuret, G.V Johnson, Tau is modified by tissue transglutaminase in situ: possible functional and metabolic effects of polyamination, J. Neurochem. 73 (1999) 1871-1880.
393. R.P. Tucker, The roles of microtubule-associated proteins in brain morphogenesis: a review, Brain Res. Rev. 15 (1990) 101-120.
394. J.C. Turpin, J.Y. Goas, M. Masson, F. Zagnoli, Y. Mocquard, N. Baumann, Type C Niemann-Pick disease: supranuclear ophthal-moplegia associated with deficient biosynthesis of cholesterol esters, Rev. Neurol. 147 (1991) 28-34.
395. M. Vandermeeren, M. Mercken, E. Vanmechelen, J. Six, A. van de Voorde, J.J. Martin, P. Cras, Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay, J. Neurochem. 61 (1993) 1828-1834.
396. M.T. Vanier, P. Neuville, L. Michalik, J.F. Launay, Expression of specific tau exons in normal and tumoral pancreatic acinar cells, J. Cell Sci. 111 (1998) 1419-1432.
397. L. Varani, M. Hasegawa, M.G. Spillantini, M.J. Smith, J.R. Murrell, B. Ghetti, A. Klug, M. Goedert, G. Varani, Structure oftau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17, Proc. Natl. Acad. Sci. USA 96 (1999) 8229-8234.
398. P. Vermersch, J.P. David, B. Frigard, C. Fallet-Bianco, A. Wattez, H. Petit, A. Delacourte, Cortical mapping of Alzheimer pathology in brains of aged non-demented subjects, Prog. Neuropsychopharmacol. Biol. Psychiatry 19 (1995) 1035-1047.
399. P. Vermersch, A. Delacourte, F. Javoy-Agid, J.J. Hauw, Y. Agid, Dementia in Parkinson's disease: biochemical evidence for cortical involvement using the immunodetection of abnormal Tau proteins, Ann. Neurol. 33 (1993) 445-450.
400. P. Vermersch, B. Frigard, J.P. David, C. Fallet-Bianco, A. Delacourte, Presence of abnormally phosphorylated Tau proteins in the entorhinal cortex of aged non-demented subjects, Neurosci. Lett. 144 (1992) 143-146.
401. P. Vermersch, B. Frigard, A. Delacourte, Mapping of neurofibrillary degeneration in Alzheimer's disease: evaluation of heterogeneity using the quantification of abnormal tau proteins, Acta Neuropathol. 85 (1992) 48-54.
402. P. Vermersch, Y. Robitaille, L. Bernier, A. Wattez, D. Gauvreau, A. Delacourte, Biochemical mapping of neurofibrillary degeneration in a case of progressive supranuclear palsy: evidence for general cortical involvement, Acta Neuropathol. 87 (1994) 572-577.
403. P. Vermersch, N. Sergeant, M.M. Ruchoux, H. Hofmann-Radvanyi, A. Wattez, H. Petit, P. Dewailly, A. Delacourte, Specific tau variants in the brains of patients with myotonic dystrophy, Neurology 47 (1996) 711-717.
404. I. Vincent, M. Rosado, P. Davies, Mitotic mechanisms in Alzheimer's disease?, J. Cell Biol. 132 (1996) 413-425.
405. R. Vulliet, S.M. Halloran, R.K. Braun, A.J. Smith, G. Lee, Proline-directed phosphorylation of human Tau protein, J. Biol. Chem. 267 (1992) 22570-22574.
406. K. Wakabayashi, S. Hayashi, A. Kakita, M. Yamada, Y. Toyoshima, M. Yoshimoto, H. Takahashi, Accumulation of alpha-synuclein/ NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy, Acta Neuropathol. 96 (1998) 445452.
407. K. Wakabayashi, K. Matsumoto, K. Takayama, M. Yoshimoto, H. Takahashi, NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease, Neurosci. Lett. 239 (1997) 45-48.
408. K. Wakabayashi, K. Oyanagi, T. Makifuchi, F. Ikuta, A. Homma, Y. Homma, Y. Horikawa, S. Tokiguchi, Corticobasal degeneration: etiopathological significance of the cytoskeletal alterations, Acta Neuropathol. 87 (1994) 545-553.
409. J.Z. Wang, I. Grundke-Iqbal, K. Iqbal, Glycosylation of micro-tubule-associated protein tau: an abnormal posttranslational modification in Alzheimer's disease, Nature Med. 2 (1996) 871-875.
410. M.D. Weingarten, A.H. Lockwood, S.Y. Hwo, M.W. Kirschner, A protein factor essential for microtubule assembly, Proc. Natl. Acad. Sci. USA 72 (1975) 1858-1862.
411. M. Wijker, Z.K. Wszolek, E.C. Wolters, M.A. Rooimans, G. Pals, R.F. Pfeiffer, T. Lynch, R.L. Rodnitzky, K.C. Wilhelmsen, F. Arwert, Localization of the gene for rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration to chromosome 17q21, Hum. Mol. Genet. 5 (1996) 151-154.
412. K.C. Wilhelmsen, T. Lynch, E. Pavlou, M. Higgins, T.G. Nygaard, Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22, Am. J. Hum. Genet. 55 (1994) 1159-1165.
413. H. Wille, G. Drewes, J. Biernat, E.M. Mandelkow, E. Mandelkow, Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro, J. Cell Biol. 118 (1992) 573-584.
414. D.M. Wilson, L.I. Binder, Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease, Am. J. Pathol. 150 (1997) 2181-2195.
415. H.M. Wisniewski, A. Robe, W. Zigman, W. Silverman, Neuro-pathological diagnosis of Alzheimer disease, J. Neuropathol. Exp. Neurol. 48 (1989) 606-609.
416. M. Yamagishi, Y. Ishizuka, K. Seki, Pathology of olfactory mucosa in patients with Alzheimer's disease, Ann. Otol. Rhinol. Laryngol. 103 (1994) 421-427.
417. H. Yamamoto, M. Hasegawa, T. Ono, K. Tashima, Y. Ihara, E. Miyamoto, Dephosphorylation of fetal-tau and paired helical filaments-tau by protein phosphatases 1 and 2A and calcineurin, J. Biochem. 118 (1995) 1224-1231.
418. H. Yamamoto, Y. Saitoh, K. Fukunaga, H. Nishimura, E. Miyamoto, Dephosphorylation of microtubule proteins by brain protein phosphatases 1 and 2A, and its effect on microtubule assembly, J. Neurochem. 50 (1988) 1614-1623.
419. S.D. Yan, S.F. Yan, X. Chen, J. Fu, M. Chen, P. Kuppusamy, M.A. Smith, G. Perry, G.C. Godman, P. Nawroth, J.L. Zweier, D. Stern, Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide, Nature Med. 1 (1995) 693-699.
420. L.S. Yang, W. Gordon-Krajcer, H. Ksiezak-Reding, Tau released from paired helical filaments with formic acid or guanidine is susceptible to calpain-mediated proteolysis, J. Neurochem. 69 (1997) 1548-1558.
421. L.S. Yang, H. Ksiezak-Reding, Calpain-induced proteolysis of normal human tau and tau associated with paired helical filaments, Eur. J. Biochem. 233 (1995) 9-17.
422. S.H. Yen, M. Hutton, M. DeTure, L.W. Ko, P. Nacharaju, Fibrillogenesis of tau: insights from tau missense mutations in FTDP-17, Brain Pathol. 9 (1999) 695-705.
423. H.S. Yin, H.C. Chou, M.M. Chiu, Changes in the microtubule proteins in the developing and transected spinal cords of the bullfrog tadpole: induction of microtubule-associated protein 2C and enhanced levels of Tau and tubulin in regenerating central axons, Neuroscience 67 (1995) 763-775.
424. M.O. Zemaitaitis, J.M. Lee, N.A. Muma, Transglutaminase-in-duced crosslinking of tau protein in progressive supranuclear palsy, Soc. Neurosci. Abstr. 25 (1999) 1095.
425. Q. Zheng-Fischhofer, J. Biernat, E.M. Mandelkow, S. Illenberger, R. Godemann, E. Mandelkow, Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical- filament-like conformation, Eur. J. Biochem. 252 (1998) 542-552.